Immune responses to ingested protein antigens in mice by Pickering, Maureen Gabrielle
IMMUNE RESPONSES TO INGESTED PROTEIN ANTIGENS IN MICE
Maureen Gabrielle Pickering B.Sc.
Thesis presented to the University of Edinburgh for the degree of







ABSTRACT OF THESIS 10
ACKNOWLEDGEMENTS 12
PUBLICATIONS 1A
LIST OF ABBREVIATIONS 15
INTRODUCTION TO EXPERIMENTS 19
CHAPTER 1 GENERAL INTRODUCTION 23
1.1 THE IMMUNOLOGICAL APPARATUS OF THE INTESTINE 24
1.2 GUT-ASSOCIATED LYMPHOID TISSUE 24
A. Peyer's patches 24
B. Intraepithelial Lymphocytes 25
C. Cellular Traffic in Gut-Associated
Lymphoid Tissue 26
D. Antigen Presenting Cells in Gut-Associated
Lymphoid Tissue 28
1.3 THE FATE OF PROTEIN ENTERING THE GASTRO¬
INTESTINAL TRACT 28
A. Protein Digestion in the Gastrointestinal
Tract 28
B. Absorption and Distribution of Macro-
molecular Protein in the Gastrointestinal
Tract 29
1.4 IMMUNE RESPONSES TO FED ANTIGENS 31
A. Local Immune Responses to Antigen in the
Gastrointestinal Tract 31




1.5 IMMUNE REGULATION 33
A. Regulation of Systemic Immune Responses 33
B. Suppressor T Lymphocytes 35
C. Mucosal Immune Regulation 35
D. The Role of Antigen Structure in Immune
Regulation 38
E. Consideration of Antigenic Structure and
Mucosal Immune Regulation A2
1.6 APPROACHES TO THE STUDY OF IMMUNE-REGULATION
IN THE CONTEXT OF GASTROINTESTINAL PROCESSING
OF ANTIGEN. A3
A. Cyclophosphamide A3
B. Ionizing Radiation A5
1.7 OVALBUMIN A6
CHAPTER 2 MATERIALS AND METHODS A8










IRRADIATION OF MICE 52
SPLEEN CELL RECONSTITUTION 52
ASSESSMENT OF DELAYED-TYPE HYPERSENSITIVITY 52
3
Page
PASSIVE HAEMAGGLUTINATION ASSAY 53
DETECTION OF ANTI-OVALBUMIN
ANTIBODIES IN MOUSE SERUM USING AN ENZYME-
LINKED IMMUNO-SORBENT ASSAY (ELISA) 54
(i) ELISA Reagents 54
(ii) ELISA For Anti-OVA Antibodies 54
DETECTION OF ANTI-HSA ANTIBODIES IN MOUSE
SERUM BY ELISA 55
DETECTION OF OVA IN MOUSE SERUM BY ELISA 56
COLLECTION OF SAMPLES FOR HISTOLOGY 57
FIXING AND STAINING HISTOLOGICAL SPECIMENS 57
INTRAEPITHELIAL LYMPHOCYTE COUNTS 57
MEASUREMENT OF INTESTINAL VILLI AND CRYPTS 57
FIXATIVES USED IN HISTOLOGY 58
STATISTICAL ANALYSIS AND PRESENTATION OF DATA 59
SECTION (b) DEVELOPMENT OF AN ANTIGEN-DRIVEN MOUSE T CELL
TRANSFORMATION ASSAY 60
INTRODUCTION 60
MOUSE T LYMPHOCYTE TRANSFORMATION ASSAY MEDIUM 60
ANTIGEN AND MITOGEN 61
PREPARATION OF A LYMPHOCYTE SUSPENSION 61







DETERMINATION OF C -THYMIDINE CONCENTRATION,




DETERMINATION OF THE OPTIMUM CELL NUMBER AND
ANTIGEN DOSE FOR OVA-SPECIFIC TRANSFORMATION 67
CONFIRMATION OF THE T CELL-DEPENDENCY OF OVA-
SPECIFIC TRANSFORMATION 67
SECTION (c) IMMUNOCHEMICAL TECHNIQUES 74
A. Preparation of Immunoadsorbent Anti-OVA
Antibodies Coupled to Sepharose (S4B-Anti-0VA) 74
ANTI-OVA ANTIBODY 74
COUPLING PROCEDURE 74
BINDING CAPACITY OF S4B-ANTI-0VA 75
"BEAD" ELISA 76
B. Standardisation of a Gel Filtration Column 79
EQUIPMENT AND RUNNING CONDITIONS 79
CALIBRATION OF THE COLUMN 79
CHAPTER 3 STUDIES in vitro OF IMMUNE REGULATION BY ANTIGEN
FEEDING 82
SECTION (a): THE INDUCTION OF SYSTEMIC TOLERANCE TO OVALBUMIN
BY FEEDING 83
3.1 INTRODUCTION 83
3.2 DESIGN OF EXPERIMENTS 84
3.3 SUPPRESSION OF SERUM ANTIBODY RESPONSES BY
FEEDING OVALBUMIN 85
3.4 SUPPRESSION OF DELAYED HYPERSENSITIVITY BY
FEEDING OVALBUMIN 87
3.5 THE EFFECT OF CYCLOPHOSPHAMIDE ON SYSTEMIC
IMMUNITY AFTER OVA FEEDING 87
Page
3.6 PROLIFERATIVE RESPONSES OF LYMPH NODE CELLS
in vitro: EFFECTS OF OVA FEEDING AND CY
PRETREATMENT 87
3.7 CONCLUSIONS AND DISCUSSION OF SECTION (a) 89
SECTION (b): LOCAL CMI REACTIONS OF PERIPHERAL AND MESENTERIC
LYMPH NODE CELLS FOLLOWING OVALBUMIN FEEDING:
EFFECTS OF CYCLOPHOSPHAMIDE PRETREATMENT 92
3.8 LYMPHOCYTE TRANSFORMATION ONE WEEK AFTER OVA
FEEDING AND THE EFFECT OF CYCLOPHOSPHAMIDE 92
3.9 TIME COURSE OF LYMPHOCYTE TRANSFORMATION IN
CY-TREATED OVA-FED MICE 98
3.10 LYMPHOCYTE TRANSFORMATION FOLLOWING OVA
FEEDING 100
3.11 CONCLUSIONS AND DISCUSSION OF SECTION (b) 102
CHAPTER 4 ORAL TOLERANCE INDUCTION BY GUT-PROCESSED
ANTIGEN 104
4.1 INTRODUCTION 105
4.2 EXPERIMENTAL DESIGN 106
4.3 SYSTEMIC RESPONSE OF SERUM RECIPIENTS 106
4.4 EFFECT OF CY PRETREATMENT OF SERUM DONORS
AND RECIPIENTS 109





CHAPTER 5 SYSTEMIC ANTIGEN DOSAGE, FORM AND IMMUNOGENICITY
STUDIED IN RELATION TO GUT-DERIVED, CIRCULATING
OVALBUMIN 11 5
5.1 INTRODUCTION 116
5.2 EXPERIMENTAL DESIGN 117
5.3 HUMORAL AND CELL-MEDIATED IMMUNITY FOLLOWING
i.v. INJECTION OF OVA 118
5.4 HUMORAL AND CELL-MEDIATED IMMUNITY FOLLOWING
i.p. INJECTION OF OVA 118
5.5 DETERMINATION OF THE ROLE OF SYSTEMIC
PROCESSING OF ANTIGEN 118
5.6 CONCLUSIONS 121
CHAPTER 6 ANTIGENIC CHARACTERISTICS OF GUT-PROCESSED
OVALBUMIN 124
6.1 INTRODUCTION 125
6.2 USE OF ANTIBODY-COUPLED SEPHAROSE AS AN
IMMUNOADSORBENT 127
6.3 TREATMENT OF SERUM TO REMOVE GUT-PROCESSED
OVA BEARING B CELL DETERMINANTS 127
6.4 OVALBUMIN CONCENTRATION IN SERUM BEFORE AND
AFTER INCUBATION WITH S4B-ANTI-0VA 128
6.5 IMMUNOGENICITY in vivo OF SERUM ABSORBED WITH
S4B-ANTI-0VA 131




CHAPTER 7 SIZE, DISTRIBUTION AND EFFECT OF OVA FRAGMENTS
GENERATED BY GUT-PROCESSING T39
7.1 INTRODUCTION 140
7.2 FRACTIONATION OF SERUM PROTEINS BY GEL FILTRATION 141
7.3 PROTEIN AND OVA CONTENT OF FRACTIONS 142
7.4 IMMUNOGENICITY OF SERUM FRACTIONS in vivo 145
7.5 CONCLUSIONS 148
CHAPTER 8 THE RELATIONSHIP BETWEEN INTESTINAL DAMAGE AND
ANTIGEN PROCESSING 150
8.1 INTRODUCTION 151
8.2 EXPERIMENTAL DESIGN 152
8.3 EFFECTS OF IRRADIATION IN BDFI MICE 152
8.4 EFFECTS OF IRRADIATION DAMAGE ON INTESTINAL ANTIGEN
PROCESSING 154
8.5 EFFECTS OF IRRADIATION AND SPLEEN CELL RECONSTI-
TUTION ON INTESTINAL ANTIGEN PROCESSING 159
8.6 COMPARISON OF THE EFFECTS OF IRRADIATION OF SERUM
DONORS WITH AND WITHOUT SPLEEN CELL RECONSTI-
TUTION 162
8.7 CONCLUSIONS - 163
CHAPTER 9 GENERAL DISCUSSION 169
9.1 INTRODUCTION 170




9.3 NATURE OF THE CIRCULATING TOLEROGEN PRODUCED BY
OVALBUMIN FEEDING 186
9.4 THE IMPORTANCE OF INTESTINAL FUNCTION AND GALT IN
THE INDUCTION OF TOLERANCE 191
9.5 CONCLUDING REMARKS 193
LIST OF REFERENCES 1 95
ADDITIONAL REFERENCES 218
9
I declare that this thesis was composed by myself and that unless
otherwise specified, the work was performed personally while I was
part of a research team.
10
ABSTRACT OF THESIS
Immunological consequences and the regulation thereof, of antigen
when introduced into the gastrointestinal tract of mice was examined
in this thesis. A protocol of feeding 25 mg of a soluble protein
antigen ovalbumin to mice which were immunologically naive with
respect to this antigen, was confirmed as a means of inducing systemic
hyporesponsiveness. Antigen-stimulated lymphocyte transformation in
vitro was then tested as a means of exploring the development of
cell-mediated immune responses in the mesenteric and peripheral lymph
nodes of mice fed with ovalbumin: after a brief, generalised
low-grade response occurring one day after feeding, results suggested
that regulatory cells are present in mesenteric lymph nodes at between
five and seven days following ovalbumin ingestion which prevent the
initiation of a local cell-mediated immune response at this time.
The main emphasis of the thesis was concerned with the role of
the antigen in inducing hyporesponsiveness. An aspect of intestinal
function, presenting antigen as a tolerogenic stimulus to the systemic
immune system following antigen feeding, was examined in serum
transfer experiments: antigen transferred with serum, which was
collected from mice one hour after a single feed of 25 mg ovalbumin,
induced tolerance for delayed-type hypersensitivity when injected into
naive syngeneic recipients and was called gut-processed antigen.
Gut-processed ovalbumin had no effect on systemic humoral immunity.
The suppressive effect of gut-processed ovalbumin on systemic
cell-mediated immunity was not antigen dose-dependent but seemed
rather the results of structural alteration to the antigen during
gut-processing. Immunoadsorption and gel filtration techniques
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revealed that gut-processed ovalbumin possessed antigenic structures
for anti-ovalbumin antibody and had an estimated molecular weight
similar to native ovalbumin. Structural alteration of the antigen to
become a tolerogen is therefore of a subtle nature.
Immuno-compromised mice treated with cyclophosphamide were not
tolerized by injection with gut-processed ovalbumin which suggests
that the tolerogen exerts its regulatory effect by activating
suppressor cells.
Mucosal integrity and perhaps also an intact GALT are important
in the intestinal processing of ovalbumin since tolerogen production
was prevented by radiation damage in the intestine but could be
restored by injecting lymphoid cells shortly after radiation.
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Antigens introduced into the gastrointestinal tract are known to
cause quite different immune responses to those observed when the same
antigens are injected parenterally. For example, specific systemic
immune tolerance is often the response to fed antigen and this can
occur with the concomitant induction of local mucosal immunity. A
growing interest has developed in the T lymphocyte - mediated
regulation of responses to antigen feeding following the
identification of different sub-populations of T lymphocytes and their
functional characterisation.
It was already known for many years, that the form in which an
antigen was administered could influence the immune response to that
antigen. For example, deaggregated proteins are often highly
tolerogenic. Chemical modification of antigen can either increase or
decrease immunogenicity depending on how the antigenic structure is
altered. More recently, it has been shown that B lymphocytes or
different T lymphocyte populations are preferentially activated
depending on the form of antigen encountered in an immune reaction.
The subject of my research therefore, has been antigen itself, in
the context of changes which may occur in an antigen which is
administered via the gastrointestinal tract as opposed to a parenteral
injection and concerned mainly with the outcome of such antigen
encounters seen in the systemic immune responses.
I chose the soluble protein ovalbumin as a model antigen for use
throughout the study. Antigen which had been absorbed into the
circulation from the intestines of mice was collected in the serum one
hour after feeding. The antigen in serum was called gut-processed
antigen and its immunological properties were defined by various in
vitro and in vivo assays.
Fairly standard experiments were first of all performed in order
to confirm the outcome of antigen feeding under controlled conditions
of antigen dosage and systemic tolerance. Once this was achieved, the
next stage in my investigation was to determine the effect of antigen
feeding on the activation of T lymphocytes in vitro after parenteral
and gastrointestinal exposure to antigen. These experiments met with
only limited success and since parallel experiments on gut-processed
antigen were proving more fruitful, I took up this latter line of
investigation more fully. Therefore, serum was collected from mice
one hour after a first-time exposure to ovalbumin introduced into the
gastrointestinal tract and then tested in order to answer several
questions about the nature of antigen after its absorption from the
gut:
What are the in vivo immunological effects of gut-processed antigen?
A biological assay was developed in order to attempt to answer this
question involving the transfer of serum from mice fed ovalbumin, into
syngeneic recipients which were later immunized and challenged in
order to assess their systemic immunity.
Does gut-processed antigen activate cells in vitro?
In a pilot study, some serum containing gut-processed ovalbumin was
added to lymphocytes in a transformation test.
How much antigen is present in serum one hour after feeding?
This question was answered by testing serum in an ELISA which measured
ovalbumin concentration.
From previous work, it was already known that pretreatment of mice
with the drug cyclophosphamide abrogates orally-induced tolerance.
Was this effect due to the action of cyclophosphamide on
gut-processing or on T lymphocytes, in particular, T suppressor cells
which are known to be sensitive to cyclophosphamide?
Both of these possibilities were explored in a series of serum
transfer experiments, where either serum donors were injected with
cyclophosphamide before feeding to investigate its effect on antigen
processing by the gut, or where serum recipients were treated with
cyclophosphamide before transfer of serum in order to examine effects
on T suppressor cells.
These experiments led to further work to examine whether
immunologically compromised hosts would be affected in their ability
to process fed antigen. A lethal dose of total body irradiation was
given to mice to produce compromised hosts which were used as donors
in serum transfer experiments. Histological examination of the
intestines of these donors obtained at post mortem, confirmed severe
gut damage with lymphoid depletion, and the effect of this on antigen
processing was tested in the recipients of serum from these mice.
Can gut-processing be reproduced by parenteral injection of modified
antigen?
This question was addressed by giving groups of mice parenteral
injections of native, deaggregated or urea-denatured ovalbumin over a
range of doses based on those concentrations measured in the serum
after ovalbumin feeding. The mice then had their systemic immunity
assessed by a standard protocol.
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Exposure to antigen can produce different effects on the humoral
and cell-mediated limbs of the immune response. Therefore, in my
studies on immune recognition of gut-processed antigen, I investigated
whether there might be differences in determinants recognised by B
cells (via surface antibody) and by T cells (via T cell receptors).
This was approached by subjecting serum from antigen-fed mice to a
variety of immunochemical techniques such as immunoadsorption to
remove antibody binding sites followed by bioassay in the serum
transfer system. Gel filtration was used as a means of obtaining
gut-processed antigen fragments within defined molecular weight limits
for testing within the serum transfer protocol. The results of these
experiments served to further elucidate the nature of gut-processed
ovalbumin both as an antigen, and as a protein entity whose molecular
size could be estimated.
CHAPTER 1
GENERAL INTRODUCT I
1.1 The Immunological Apparatus of the Intestine
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Within the gastrointestinal tract are many areas of organised
lymphoid tissue such as the Peyer's patches. There are also cells
dispersed under and within the mucosal epithelium which are capable of
taking part in specific immune reactions.
In addition to specific immunity, various types of cells,
including mononuclear phagocytes and mucosal mast cells, and
physiological factors such as gastric acid, lysozyme and peristalsis
enhance non-specific immunity in the gut (Ferguson and Mowat, 1980).
Under certain conditions, mucosal mast cells can release histamine and
cause increased secretion of mucus by goblet cells. Mucus, which
coats the epithelial surface of the gut and forms an important
protective covering can prevent the attachment of antigens to the
epithelium and even facilitate their clearance from the intestinal
lumen, (Woloschak and Tomasi, 1983). Gut epithelial cells are being
continuously exfoliated into the lumen and so non-specific immunity is
also maintained by the continued renewal of the absorptive surface of
the intestine (Ferguson and Mowat, 1980).
1.2 Gut-Associated Lymphoid Tissue
A. PEYER'S PATCHES
Distributed throughout the epithelial membrane of the
gastrointestinal tract, Peyer's patches can be seen as visible,
non-encapsulated nodules of lymphoid tissue containing predominantly
lymphocytes. The size and number of Peyer' s patches varies with age
(in humans), size increasing with age, whereas the total number of
Peyer's patches decreases from puberty after an initial increase from
birth. Each Peyer's patch contains a variable number of lymphoid
follicles and is one follicle thick (Cornes, 1965).
From studies using electron microscopy, Peyer's patches appear
smooth and round, projecting into the gut lumen. Some of the
epithelial cells covering Peyer's patches are known as "microfold" or
M cells because of the many-folded ridges on their surfaces (Owen and
Jones, 1974). M cells possess many intracellular vesicles which are
thought to be used by the M cell in the transport of antigenic
material from the gut to the underlying lymphoid cells, where the
sensitisation of lymphocytes can occur (Woloschak and Tomasi, 1983).
B. INTRAEPITHELIAL LYMPHOCYTES
Intraepithelial lymphocytes are found, as their name suggests,
between adjacent mucosal epithelial cells and concentrated in the
basal part of the villus epithelium (Ferguson, 1977). They vary in
their distribution along the gastrointestinal tract and increase in
number during certain disease processes (Ferguson, 1976). The number
of intraepithelial lymphocytes is also influenced by age, microbial
antigens, parasitic infections, irradiation and immunosuppressive
drugs (Ferguson, 1977). Intraepithelial lymphocytes can cross the
basement membranes in both directions. They are generally larger than
peripheral blood lymphocytes and can contain cytoplasmic granules many
of which resemble mast cell granules (Woloschak and Tomasi, 1983;
Ferguson, 1977).
Different types of cells have been identified as intraepithelial
lymphocytes (Woloschak and Tomasi, 1983). For example the OKT 8
antigen associated with suppressor/cytotoxic function, has been found
on 70% of human intraepithelial T lymphocytes. Both T and B cells
have been identified in the intraepithelial lymphocyte populations of
experimental animals and a recent study in mice (Mowat et al, 1983),
reports the presence of intraepithelial lymphocytes with null-killer
(NK) activity together with the presence of NK-regulating cells.
Other intraepithelial cells which have been observed include
eosinophils and globule leukocytes or mast cells (Collan, 1977).
C. CELLULAR TRAFFIC IN GUT-ASSOCIATED LYMPHOID TISSUE
In many different experiments, small T and B lymphocytes have
been seen to "traffic" or migrate from the bloodstream into the
Peyer's patches as well as to the lymph nodes and spleen. However,
these small lymphocytes do not "home" to the intestinal mucosa. In
contrast, studies on mice, rats and rabbits have shown that after
sensitisation by antigen, B lymphocytes in Peyer's patches divide to
become lymphoblasts which then migrate via the lymphatics to exocrine
tissues such as the mammary and salivary glands (Woloschak and Tomasi,
1983), where they differentiate into plasma cells secreting IgA.
Thoracic duct lymphocytes are not the only source of lamina
propria lymphocytes as seen when thoracic duct lymphocytes were
diverted from the gut: whilst the number of IgA-plasma cells
decreased in the lamina propria, it was not depleted of cells
(Woloschak and Tomasi, 1983). This suggests that either some other
source of plasma cells is capable of populating the lamina propria or
that plasma cell numbers are maintained by local cell division. This
idea is supported by experiments which showed that lamina propria
cells can re-populate irradiated recipients in cell transfer
experiments (Woloschak and Tomasi, 1983).
The migration of IgA-plasma cell precursors to the lamina propria
occurs independently of gut antigen, but the presence of antigen
influences the number and distribution of migrating cells (Woloschak
and Tomasi, 1983: Ferguson, 1978), a greater density of plasma cells
being found at the site of antigen challenge (Pierce and Gowans,
1975).
There is, as yet, no established mechanism to explain the
localisation of IgA precursors in the gut tissues. One model proposes
a receptor for IgA precursors within the vascular compartment of the
gut, another, that lymphoblasts migrate into the gut from the
circulation at random, but that IgA-committed cells have an enhanced
ability to proliferate in mucosal tissues (Woloschak and Tomasi,
1983).
Experimental evidence is still lacking for an explanation of the
regulation of lympnoblast homing to the gut although it seems that
there is a relationship between lymphoblast accumulation in a segment
of gut, and the regional blood flow to that area (Ottaway and Parrot,
1980). Hormones can influence lymphocyte homing to mucosal tissues
(Bienenstock and Befus, 1980), and T cells may play a role in the
selective retention of B lymphoblasts in the lamina propria since T
cells of mesenteric lymph nodes home to the gut (Guy-Grand et al,
1978).
In addition to the homing of lymphoblasts from lymph to lamina
propria, animal experiments have confirmed the migration of cells from
lymph to the intraepithelial site (Guy-Grand _et al, 1974: Parrot et_
al, 1975). Lymphocytes destined to enter the epithelium leave the
bloodstream via capillaries in the villi. The route by which
intraepithelial lymphocytes leave the epithelium is not yet
established, but it is thought likely that these cells re-enter the
lamina propria and leave the villi in the lymphatics (Ferguson, 1977).
D. ANTIGEN PRESENTING CELLS IN GUT-ASSOCIATED LYMPHOID TISSUES
Various antigen presenting cells have been described in Peyer's
patches and the intestinal lamina propria. These include macrophages
(Richman et al, 1981; Mayrhofer _et al, 1983), and also non-phagocytic
dendritic cells which bear la antigen on their surface (Mayrhofer et
al, 1983). These latter cells are found in the lamina propria of the
villi and crypts and in Peyer's patches, both in the sub-epithelial
region and within the epithelium itself. In addition to these
accessory cells, the gastrointestinal epithelial cells can express la
antigens on their surfaces (Mayrhofer et al, 1983), a marker
associated with antigen presenting ability, and thus suggesting a
possible role for the gut epithelium in local antigen presentation.
1.3 The Fate of Protein Entering the Gastrointestinal Tract
The immunological properties of the small intestine cannot be
considered in isolation from the digestive properties of this complex
organ. Digestion and absorption of both endogenous and exogenous
(dietary) protein is one of the principal functions of the
gastrointestinal tract and is an extremely efficient process (Reviewed
by Freeman and Kim, 1978).
A. PROTEIN DIGESTION IN THE GASTROINTESTINAL TRACT
Protein digestion is initiated in the stomach when the major
gastric protease, pepsin, is activated from pepsinogen. Gastric phase
digestion is influenced by hormones and other, nonhormonal factors
such as gastric acid and rate of gastric emptying. Gastric phase
protein digestion gives way to intestinal digestion by proteases
released by the pancreas.
Digestion by pancreatic enzymes is more critical than the gastric
phase of digestion. Activated pure pancreatic juice contains both
endopeptidases and exopeptidases, and the products of their combined
action are small peptides and free amino acids, the small peptides
accounting for more than 60% of intestinal amino acid nitrogen. The
final digestion phase of most luminal peptides involves digestion by
peptidases of the brush border and cytoplasm of intestinal mucosal
cells, to produce free amino acids which are non-antigenic. These
end-products of protein digestion are then transported across the
mucosa via specific active transport systems and enter the portal
blood flowing into the liver.
B. ABSORPTION AND DISTRIBUTION OF MACROMOLECULAR PROTEIN IN THE
GASTROINTESTINAL TRACT
Along with amino acids and di- and tri-peptides, whole proteins
and other large macromolecules are absorbed in amounts which are of
little or no nutritional significance but may well be biologically or
immunologically significant. Large molecules are absorbed intact by
foetal and neonatal small intestine and several studies suggest that
macromolecules can cross the mature mucosal barrier under normal
physiological conditions, (Kiishaw and Slade, 1980: Warshaw et al,
1974: Swarbrick, 1979), and that there may be uptake of different
amounts of macromolecules at different sites along the intestine
(Morris and Morris, 1976). One study in humans (Adibi and Mercer,
1973), demonstrated that protein can be found in both the jejunum and
ileum as late as four hours after ingestion. These experiments
illustrated the passage of protein right along the small intestine to
the ileum, enabling the absorption of protein to occur, all along the
intestine.
One mechanism by which gut antigens may cross the mucosa, is by
means of epithelial cell pinocytosis followed by the deposition of
macromolecules in the interstitial space (Reviewed, Walker, 1981).
Antigens can then enter the circulation if not taken up by
macrophages, or by liver Kupffer cells. Some observations have also
been made of intercellular absorption of macromolecules (Reviewed,
Woloschak and Tomasi, 1983), and specialised antigen transport by M
cells is one mechanism whereby antigens gairr access to the gut
lymphoid tissue (Walker, 1981).
Many different estimates of the amount of macromolecular protein
crossing the mucosa into the systemic circulation have been reported
by several workers using various experimental techniques. The results
quoted range from greater than 40% of ingested dose being absorbed in
rats (Morris and Morris, 1976), to as little as 0.01% of the ingested
dose per millilitre of serum in mice (Hanson, personal communication,
1982; Strobel _et al_, 1983). Several experiments estimate antigen
uptake from the gut into the systemic circulation by measuring levels
of radiolabelled antigen in serum,(Hammings et al, 1977, Seifert, et al,
Such experiments should be interpreted with caution since
the presence of radioactivity may not be concornit ant with
the presence of macromolecules unless appropriate precautions
are taken to ensure that no free label appears in the plasma
(Skogh, 1982), or that neither free label nor labelled protein
fragments are bound to endogenous plasma proteins (Udall et_ al, 1981).
In experiments to be described in this thesis, immunological
techniques have been used to assay macromolecular uptake
from the gut. It should be borne in mind that even these
techniques incur some overestimation since an antigen binding
site detected by specific antibody may reflect antigen fragments
bound to plasma proteins and not attached to a large molecule.
1.4 Immune Responses to Fed Antigens
The presence of antigen in the gastrointestinal tract may induce
any of several different manifestations of local and/or systemic
immune responses.
A. LOCAL IMMUNE RESPONSES TO ANTIGEN IN THE GASTROINTESTINAL TRACT
Immunoglobulins A, M, G and E are found in the secretions of the
gut mucosa and it is now textbook knowledge that IgA is the
predominant secretory antibody. A secretory antibody response can
occur in the absence of serum antibody and so provide specific
immunological resistance at mucosal surfaces. (Bienenstock and Befus,
1980, 1983; Heremans, 1974 ; Tomasi, 1976). However, not all mucosal
responses are favourable for the host since Type-I hypersensitivity
reactions (IgE-mediated), can occur in the gut causing oedema and
reddening of the mucosa (Reviewed, Ferguson and Mowat, 1980).
The various T cell-mediated mucosal responses occurring as a
result of antigenic stimulus in the gut are now well documented also.
Local delayed-type hypersensitivity has been described, (MacDonald and
Ferguson, 1977; Mowat and Ferguson, 1981 a; Mowat and Ferguson, 1981
b), and cytotoxic T cells have been detected in Peyer's patches and
extraintestinal sites after oral immunization (Kagnoff, 1978 a).
Other manifestations of local immunity in the gut include
hyperplasia of mast cells and of goblet cells. Goblet cells
release mucus in response to local antigen. In addition, Peyer's
patch macrophages may provide non-specific resistance (MacDonald _et_ al, 1982).
B. SYSTEMIC RESPONSES TO ANTIGEN IN THE GASTROINTESTINAL TRACT
The presence of antigen in the gastrointestinal tract can induce
a variety of systemic immune responses ranging from humoral and
cell-mediated immune responses, to suppression of either or both types
of these responses, or even no net effect. The response induced is
dependent on the dose and nature of antigen, the species, strain and
age of experimental animal used and the type of antigen feeding
protocol adopted in experiments.
For example, circulating antibodies have been observed after
antigen feeding (Rothberg and Farr, 1965), and serum IgE can be induced
by feeding small doses of antigen to rats given Bordetella pertussis
systemically (Jarrett et al. 1976: Bazin and Platteau, 1976). Mice
fed killed Escherichia coli showed enhanced serum antibody production
in response to a subsequent parenteral immunization indicating that
feeding the antigen had induced some degree of systemic priming
(Stokes et al, 1979). This enhancement was associated with feeding
small amounts of antigen whereas larger amounts of antigen or a more
prolonged feeding regimen tended to induce hyporesponsiveness.
Systemic hyporesponsiveness ofhumoral and cell-mediated immunity
following antigen feeding or, oral tolerance, is a long-established
phenomenon having been observed by Dakin in 1829 as a practice among
Red Indians who ate Rhus leaves in order to prevent contact
sensitivity, or "poison ivy" on later contact with the leaves. This
phenomenon was later studied scientifically by Wells (Wells 1911;
Wells and Osborne, 1911), and since then, oral tolerance has been
studied in several species and strains of experimental animals and to
various soluble and particulate antigens including contact sensitising
agents (Chase 1946; Asherson et al, 1977), bovine serum albumin, in
rats (Thomas and Parrott, 1974), sheep erythrocytes in mice (Kagnoff,
1978 b, c) and rats (Mattingly and Waksman, 1978 ), and
ovalbumin in mice (Hanson et al, 1977; Hanson et al, 1979; Miller
and Hanson, 1979; Richman et al, 1978; Ngan and Kind, 1978).
Serum antibody responses can be suppressed by feeding after
systemic immunization (Lafont et _al, 1982) and the responses of
suckling animals can be suppressed by maternal ingestion of antigen
(Jarrett and Hall, 1979; Peri and Rothberg, 1981). Orally induced
systemic tolerance may also occur concurrently with an intestinal
secretory antibody response (Challacombe and Tomasi, 1980; Stokes et
al, 1979), and this may indicate a regulatory mechanism whereby
antigen in the gut is dealt with locally, while inappropriate or even
damaging systemic immune responses are suppressed.
1.5 Immune Regulation
A. REGULATION OF SYSTEMIC IMMUNE RESPONSES
Each response made by the immune system is highly amplified and
subject to strict control. In the case of T lymphocytes, this control
is exerted by products of the Major Histocompatibility gene complex or
MHC (Reviewed, Howie and MacBride, 1982).
The initiating event in an immune response is antigen recognition
by lymphocyte surface receptors. These serve to bring cells of the
immune system into contact with each other such that further signals
may be transmitted between them depending on to which functional
compartment the lymphocytes belong. The result of these signals may
be activation, differentiation or suppression of target cells. Some
lymphocytes recognize idiotypes, which are determinants associated
with the antigen binding site of antibodies, and possess surface
receptors for these determinants which are anti-idiotypic in nature
and not anti-antigen. It is possible that interaction can also occur
via anti-idiotype receptors on cells.(Reviewed, Urbain and Wuilmart, 1982).
Examples of immunological signals are interleukins. These
are molecules released by lymphocytes and antigen presenting
cells which stimulate other cells of the immune system. Down-regulation of an
immune response produces a state of immunological tolerance. This can
be defined as a condition of specific hyporesponsiveness to an antigen
which would be immunogenic in other circumstances. Lymphocytes of T
or B classes, or both, can be tolerized in animals and, like a
positive immune response, tolerance is influenced by the genetic
constitution of the host, the mode of antigen presentation and the
nature and amount of antigen presented. Tolerance mechanisms differ
with experimental systems. In some experimental models, tolerance is
associated with a loss of B cell activity (Aldo-Benson and Borel,
1974; Parks and Weigle, 1980 a), loss of helper T cell function
(Parks and Weigle, 1980 b), induction of suppressor B cells (Asherson
et al, 1977), and activation of suppressor T cells (Sy et al, 1977;
Basten et al, 1974). In some instances, unresponsiveness can be
dissociated from T suppressor cell activity by criteria such as;
kinetics of tolerance induction, drug sensitivity and dose of antigen
required (Sherr et al, 1979; Colby and Strejan, 1980), and more than
one regulatory mechanism may be active in the same animal.
B. SUPPRESSOR T LYMPHOCYTES
Suppressor T cells have often been implicated in the suppression
of cell-mediated immune responses in mice (Sy et al, 1977; Asherson
and Zembala, 1980), and different functional classes of suppressor
cells, including suppressor memory cells, exist within this
sub-population (Liew and Howard, 1980; Whisler and Stobo, 1978).
Suppressor cells can act afferently, blocking the induction of
responses, or efferently, preventing the action of effector cells
after priming has occurred. Different types of suppressor T cells may
be responsible at different stages of the cell-cell interaction
pathway. For example, "auxiliary" suppressor cells are activated by
antigen and can cause efferent suppressor cells to exert their
inhibitory effect on T cells primed for a delayed hypersensitivity
response (Sy et al, 1979). This illustrates the kind of complex
pathways by which immune responses are regulated. Some of these
complications could well disappear with future research since at
present it is not clear whether some effector-suppressor cells
represent mature activated forms of inducer-suppressor cells or are in
fact separate sub-populations of cells (Germain and Benacerraf, 1981).
C. MUCOSAL IMMUNE REGULATION
The gut mucosa is in constant contact with various immunogenic
and even potentially immunoregulatory substances. It is essential,
therefore, that responses to antigens in the gastrointestinal tract
are carefully regulated.
Oral tolerance, the systemic unresponsiveness observed following
antigen feeding is a product of this regulation although the mechanism
of this phenomenon is not clear and, like systemic immunity, may be
governed by different mechanisms since serum antibody (Kagnoff, 1978
c), antigen-antibody complexes (Andre' at al, 1975), and suppressor
cells (Thomas and Parrot, 1974; Asherson et al, 1977; Ngan and Kind,
1978: Mattingly and Waksman, 1978), have all been reported.
T cell-mediated suppression following oral administration of
antigen may extend only to IgM or IgG responses but not to secretory
IgA (slgA) responses since murine Peyer's patches after antigen
feeding have been found to contain suppressor cells for IgM and IgG
production together with helper T cells for slgA responses (Richman et
al, 1981). This is supported by the data of Challacombe and Tomasi
(Challacombe and Tomasi, 1980), where antigen feeding induced systemic
tolerance for antibody together with a salivary IgA response.
In vitro work using cloned T cells from Peyer's patches has
revealed the presence of isotype-specific "switch" T cells which
induce IgM-bearing B cells to differentiate into IgA-bearing B cells
(Strober, 1982). These cells may be providing the net T cell "help"
for IgA responses described in earlier work by the same group of
workers (Richman et al, 1981).
Other in vitro studies have demonstrated cells of the
contra-suppressor circuit in Peyer's patches. Contra-suppressor cells
inhibit the activity of suppressor cells and their cell-free mediators
and it has been postulated that contra-suppression allows immune
responses to occur in microenvironments like the gut despite
suppression of the systemic immune response (Green et al, 1982).
There has, as yet been no in vivo demonstration of such a system
operating in the intestine.
Mucosal antibody, whilst being protective may also have a
regulatory function in limiting the entry of antigen into the systemic
circulation. Everted gut sacs from orally immunized rats show reduced
passage of specific antigen across the mucosa when compared with gut
sacs from non-immune rats (Walker and Isselbacher, 1972). This
phenomenon is known as immune exclusion and although IgA can cause
immune exclusion at the bronchial mucosal surface (Stokes et_ al,
1975), this function is not exclusive to IgA since both IgA and IgG
were detected in washings and scrapings of the gut sacs used by Walker
et al (1972, 1975). The presence of specific antibody at the gut
mucosa of rats causes antigen to be absorbed on to the mucosal surface
with the formation of immune complexes (Walker et al, 1975). This in
turn stimulates mucus release from goblet cells allowing the rapid
elimination of antigen to occur in the gut lumen (Walker, 1977).
Immune exclusion is not just a property of everted gut sacs.
Swarbrick measured the amount of antigen absorbed into the serum of
mice after feeding and was able to demonstrate in vivo that oral
immunization with a protein antigen reduces its subsequent absorption
(Swarbrick, 1979).
Non-specific mechanisms such as gut flora, also feature in
mucosal regulation. Bacterial lipopolysaccharide present in the gut
lumen can induce suppression of immune responses (McGhee ^et al, 1980).
On the other hand, prior activation of the reticuloendothelial system
of mice leads to the abrogation of oral tolerance to ovalbumin and
instead, results in an active mucosal delayed hypersensitivity
response in the mucosa and mesenteric lymph nodes (Mowat and Parrott?
1983). A regulatory role has also been suggested for the liver
Kupffer cells since re-routing of the gastrointestinal venous blood to
by-pass the liver abrogates oral tolerance (Cantor and Dumont, 1967).
Appropriate regulation of mucosal and systemic immune responses
is an important consequence of antigen feeding since perturbation of
any of these regulatory mechanisms may evoke inappropriate and even
harmful immune reactions either in the gut mucosa or systemically.
This idea is borne out to some extent by data showing that the
induction of a local CMI reaction in the intestinal mucosa following
the abrogation of suppressor cell activity, led to changes in mucosal
architecture similar to those seen in diseased intestines (Mowat and
Ferguson, 1981). This gives some indication of the importance of
active suppression of harmful immune responses to ingested antigens in
protecting the host.
D. THE ROLE OF ANTIGEN STRUCTURE IN IMMUNE REGULATION
Several different determinants on complex antigens participate in
the regulation of immune responses. This concept has arisen from
experiments showing that antigens which have been structurally altered
will evoke quite different sorts of immune responses compared to the
original antigen and even influence subsequent responses to that
original unaltered antigen. Deaggregated protein antigens are
tolerogenic (Dresser, 1962) for example, and fragments of bacterial
flagella antigens obtained by Cyanogen Bromide cleavage suppress
responses to the intact antigen (Ada and Parish, 1968). It is also
well known that heat-aggregated protein antigens will elicit a more
powerful delayed hypersensitivity (DTH) reaction in mice primed with
native antigen than the native antigen itself (Titus and Chiller,
1981). An increase in antigenicity proportional to the loss of
°c-helix content in protein tertiary structure was achieved by
mercaptoethanol reduction of BSA. As the helix conformation is lost,
it is possible that either new antigenic determinants are created or
that hidden determinants are revealed thereby increasing the antigenic
stimuli associated with the protein (Goetzl and Peters, 1972).
In early studies on DTH, heat denaturation of soluble protein
antigens altered the antigenicity of the protein with respect to
antibody production whilst DTH responses were identical to either
native or heat denatured protein (Gell and Benacerraf, 1959). This
split in responsiveness of the humoral and cell-mediated arms of
immunity due to altered antigen structure reflected the different
structural requirements for the induction of B and T cell responses
against complex protein antigens. Further experimental support for
this idea was provided when urea-denatured antigens were found to be
capable of affecting T cells specific for the native antigen and
causing suppression of the serum IgE response to the native antigen
despite the destruction of the majority of serologically detectable
determinants during denaturation (Ishizaka et al, 1979). The
suppression of IgE responses by modified antigen has potential as a
therapy for allergic disease and indeed, in animal models, allergens
and allergenic haptens can be converted to non-immunogenic and
tolerogenic derivatives by conjugation to non-immunogenic synthetic
polymers (Reviewed, Sehon, 1982).
Antigen fragments which are not recognised by B cells by virtue
of having no antibody binding sites can suppress antibody responses by
activating suppressor T cells (Michael _et al, 1981), and the different
T cell subclasses may also possess different structural requirements
for their activation. Suppressor T cells induced in response to
urea-denatured ovalbumin (OVA) suppress the in vitro proliferative
response to urea-denatured OVA and do not suppress the response to
native OVA. In a likewise manner, suppressor cells induced to native
OVA do not suppress the response to urea-denatured OVA. However,
helper T cells in the same experimental system will recognise both
native and denatured antigen regardless of which antigen form they are
induced with (Endres and Grey, 1980 a). These results seem at first
to conflict with the data of Ishizaka _et al, (1979), however, both
groups used slightly different methods to prepare the urea-denatured
antigen and measured suppression in different arms of the immune
response; in one case the IgE response and in the other the
proliferative response. These types of responses could well involve
different pathways of cell interactions or even different suppressor
cell populations.
Genetically determined high and low responder mice have proved
useful in investigating the importance of antigen structure in immune
to s
responses under Ir gene control. For example, H-2 and H-2 mice are
low antibody responders to hen egg white lysozyme because they produce
a predominance of suppressor cells specific for a suppressor
determinant on the molecule which is 27 amino acids long and known as
the N-C peptide (Sercarz et al, 1978; Adorini et al, 1979). In
elegant experiments where the N-C peptide was excised, the low
responder mice behaved as high responders and produced helper T cells
specific for a different portion of the molecule; the so-called LII
fragment. This illustrates that suppressor and helper T cells respond
to different structural determinants on the same molecule and that
strain differences in responsiveness may reflect immunodominance of
either helper or suppressor determinants. In these experiments it is
interesting to note that the suppressor determinant is a peptide of
only 27 amino acids. Different T cell subclasses then, are capable of
recognizing fragments of globular protein antigens, in this case
fragments perhaps conserving only part of the primary protein
sequence, and can affect the response to the whole native protein.
That T cells recognise primary protein structure has previously been
proposed by Benacerraf, (1978), in reference to "processed" antigen
associated with la molecules on the surface of antigen presenting
cells.
Antigen processing and presentation in vivo by macrophages and
other antigen presenting cells allows for the selection and
presentation of the appropriate antigenic determinants to lymphocytes
and there is some indirect evidence that antigen which is not
processed by macrophages preferentially activates suppressor T cells
(Endres and Grey, 1980 a; Yoshikai et al, 1981). In addition, animal
strain differences in susceptibility to tolerance can reflect
differences in antigen handling by macrophages either in processing or
presentation of antigen in the induction phase of immunity. For
example, in one study C57B1/6 mice were more easily tolerised by
deaggregated human Y—globulin (HGG) than were BALB/c J mice. This was
due to inefficient processing by C57B1/6 macrophages of trace amounts
of HGG aggregates in the deaggregated antigen preparation (Golub and
Weigle, 1967). Further to this, BALB/c mice given Carageenan which
poisons macrophages, lost their "resistance" to tolerance induction
with deaggregated protein, (Lukic et al, 1975). Clearly the nature of
antigen presented in the immune system can exert a powerful regulatory
influence.
E. CONSIDERATION OF ANTIGENIC STRUCTURE AND MUCOSAL IMMUNE REGULATION
By virtue of the digestive and absorptive functions of the gut,
protein antigen entering the host via the gastrointestinal tract is
more likely to experience structural alteration than native protein
injected systemically. Antigen structure is a determining factor in
the outcome of immune recognition and so the gut feasibly has a unique
role to play in influencing antigen conformation which will in turn
influence the type of immune response evoked by feeding antigen.
Studies on cholera antigen have shown that different antigen
forms presented at mucosal surfaces will produce changes in the
kinetics and magnitude of the mucosal antibody response (Pierce,
1978). However, little is known of the antigen forms presented to the
systemic immune system via the gut which occur as products of the
combined physiological and immunological properties of the intestine.
These include digestion, immune exclusion, absorption, and can extend
to include liver filtration. This combined effect can be described as
gut-processing of antigen or antigen handling by the gut and is
dependent therefore, on the genetic and immunological constitution of
the host (Swarbrick, 1979), the physiological status of the gut and
the molecular conformation of the antigen. Ovalbumin for example, has
a very rigid structure and there is some evidence that this protein is
not readily digestible with trypsin or chymotrypsin in vitro (Yokota
et al, 1982).
In one in vivo study of antigen handling by the gut, serum was
collected after feeding ovalbumin to mice and assayed by gel
filtration. Ovalbumin was found only in the fraction corresponding to
the molecular weight of native ovalbumin (Swarbrick, 1979). This is
at variance with the implications of the in vitro experiments of
Michael et al, who found that fragments of bovine serum albumin
obtained by in vitro proteolysis with pepsin suppress the antibody
response to native bovine serum albumin when injected into mice prior
to immunization. These fragments induce suppressor T cells in the
mice and will tolerize B cells if conjugated to homologous ^--globulin
(Michael et al, 1981). Whether similar fragments are generated in the
circulation after in vivo protein digestion is not clear at present
and was a subject for study in this thesis.
1.6 Approaches to the Study of Immune Regulation in the Context of
Gastrointestinal Processing of Antigen
In order to investigate the roles of both antigen handling by the
gut and suppressor T cells in oral tolerance, and to learn more of the
relationship between mucosal damage and immunity, systemic immune
responses were studied in animals which had been compromised by
disruption either of their normal regulatory mechanisms of immunity or
of their normal gut functions. This disruption was achieved by
treating mice with the drug cyclophosphamide: (this had been
extensively studied in the research programmes of Dr Allan Mowat and
Dr Stephan Strobel in this laboratory, investigating the effect of the
drug on oral tolerance control mechanisms) f and also by subjecting mice
to whole body irradiation.
A. CYCLOPHOSPHAMIDE
Cyclophosphamide (CY), is an alkylating agent which, upon
injection into the host, is rendered biologically active by the liver
and can then disrupt DNA synthesis in host cells, (Foley _et al, 1961).
It follows that a primary target for this drug will be actively
dividing cells and so when CY is injected shortly after immunization
of the host, when cells of the immune system are normally in a state
of proliferation, cell division is inhibited and the immune response
is suppressed (Ramshaw et al, 1976). If injected prior to
immunization, CY can either selectively enhance or deplete
cell-mediated immunity depending on the dose of CY administered. For
example, a dose in the 20-200 mg per kilogram body weight range
enhances delayed hypersensitivity responses (Diamantstein e_t al_, 1981;
Atallah et al, 1979). In some cases, increased cell-mediated immunity
due to CY treatment is associated with depletion of B cells from
lymphoid tissue (Turk and Parker, 1982). CY will reverse tolerance
when suppressor cells are responsible (Turk and Parker, 1982; Sy et
al, 1977), and can also enhance immune responses following their
depression by antigenic competition (Dwyer et ail_, 1981).
Cells of the intestinal epithelium are constantly in a state of
renewal (Reviewed, Leblond, 1980), and as such are sensitive to the
alkylating properties of CY. Cyclophosphamide administration causes
rapid inhibition of crypt cell mitosis followed by a regeneration
period during which time crypt cell proliferation is higher than
normal and crypt cell death and extrusion can be seen (Rosenoff et al,
1975; Ecknauer, 1976; Young 1976; Sobhon et_ al, 1977). It is not
known whether these morphological changes reflect any difference in
the absorptive capacity of the gut or of antigen handling, and in this
respect the dose of CY may be important since a single dose of 100
mg/kg of CY which is sufficient to produce morphological changes, only
minimally affects enzyme activity or sugar absorption in the gut
epithelium of rats (Ecknauer, 1976).
B. IONIZING RADIATION
Organised lymphoid tissues and recirculating small lymphocytes
are exquisitely radiosensitive and the effects of radiation on all
aspects of immunity are now well documented (Taliaferro et al, 1964;
Anderson and Warner, 1975). Briefly, the death of cells due to
irradiation can be defined as either (i) reproductive death where the
ability of the cell to divide is destroyed, or (ii) interphase death
which is characteristic of small lymphocytes and describes the death
of cells almost immediately after exposure to irradiation without
mitosis occurring. Small B cells are more sensitive than small T
cells (Anderson et al, 1974), and activated T cells are resistant to
radiation-induced interphase death as they have developed beyond the
proliferation stages of differentiation and clonal expansion (Hamaoka
et al, 1972).
One important source of disruption of immune mechanisms following
irradiation is its effect on cell traffic (Reviewed, Anderson and
Warner, 1975). Whole body irradiation causes a sharp decrease in
numbers of recirculating small lymphocytes due to the impaired
capacity of these cells to traffic normally. This dysfunction was
illustrated by Kettman and Matthews who showed that delayed
hypersensitivity to sheep erythrocytes can be transferred into normal
mice only when the irradiated primed spleen cells are injected with
antigen directly into the footpad. An intravenous injection of these
cells fails to sensitise normal mice because normal cell traffic is
impaired (Kettman and Matthews, 1976).
In the intestine, the constant division and renewal of cells in
the intestinal epithelium renders this organ highly sensitive to
radiation damage (Reviewed, Quastler, 1962). Within one hour
following irradiation, focal oedema of villi can be detected along
with distortion of crypt cell proliferation, mitosis being virtually
abolished by 24 hours. In addition, cells are not extruded from the
tips of the villi for the first 12 hours following irradiation. In
rats, shorter villi and longer crypts are seen within a few days due
to regeneration of epithelial cells over the damaged mucosa. The
villous epithelium is recovered in appearance after 5-7 days although
in.testinal function, which is lowest 3 days after irradiation begins
to recover at 4-6 days, with full recovery taking as long as 10-17
days (Detrick e_t al, 1963).
1.7 Ovalbumin
The protein ovalbumin (OVA) was chosen as an antigen for use
throughout the work of this thesis for a variety of reasons: it is a
soluble protein, available in commercially purified form and is not
normally encountered in the diet of mice reared in this animal unit.
Various physical and chemical properties of OVA have been
comprehensively reviewed (Vadehra and Nath, 1973): ovalbumin
constitutes around 54% of the protein in egg white and is usually
isolated by crystallisation. It has a molecular weight of 43,500
daltons and is the only egg white protein which bears free sulphydx^yl
groups. Ovalbumin also has a carbohydrate moiety which comprises 3.5%
of the molecule. The carbohydrate is mainly in the form of mannose
with a small amount of galactose also present. The dominant amino
sugar of OVA is glucosamine but fucose and sialic acid residues are
also present in minute quantities. Ovalbumin is easily denatured by
urea, guanidium salts, thiocyanate and heat, in which case aggregates
of varying length are produced depending on the concentration of OVA
and time of heating. Other physical parameters which change during
denaturation include viscosity, light scattering and ultracentrifugal
behaviour with minimal changes observed on electrophoresis of native
and denatured OVA.
The sequencing of messenger RNA for chicken ovalbumin has
revealed information about the primary amino acid sequence of OVA.
This consists of 385 amino acid residues from N-terminal
acetyl-glycine to C-terminal proline with carbohydrate attached to the
molecule at Asparagine-292. Ovalbumin is also a phosphorylated
protein and has a single intra-chain disulphide bond. In addition,
different genetic variants or allelic forms of OVA exist (McReynolds
et al, 1978).
Immunochemical analysis of crystalline OVA shows the presence of
3 fractions: Al, A2 and A3, which differ from each other on the basis
of phosphorous content. A3 is the molecule initially synthesised and
is most susceptible to denaturation. A2 and Al are transformed
varieties of the original protein with A2 being more susceptible to
denaturation than Al (Rhodes et al, 1958: Vadehra and Nath, 1973).
Ovalbumin has been identified as a major allergen in hen's egg white
(Langeland, 1982), and part of its antigenic determinants have been






GENERAL MATERIALS AND METHODS
Animals
BALB/c mice and BDF1 mice (crosses between DBA/2 males and
C57B1/6J females) were bred and maintained in the Animal Unit of the
Western General Hospital, Edinburgh. Adult male and female animals
were used mainly at between 6 and 8 weeks of age. They were fed ad
libitum on normal laboratory rodent diets which contained no chicken
or egg proteins (Spratt's No. 1; Spratt's Patent Ltd: CRM (X);
Labsure) and allowed unlimited access to tap water. Unless otherwise
stated, groups of 5 to 6 animals were routinely used for experiments.
Antigens
Ovalbumin or OVA (chicken albumin, Grade V; Sigma Chemical Co.)
was most frequently used throughout the work. Human serum albumin or
HSA (Sigma) was used as a non-cross-reacting protein.
Denatured OVA was prepared according to the method of Chesnut,
Endres and Grey (1980): OVA (15mg/ml) was dissolved in 0.1M Tris
buffer (BDH) at pH 8.2. Solid Urea (Sigma) was added to a final
concentration of 8M and 2-mercaptoethanol (Sigma) to a final
concentration of 0.2M.
Reduction of native OVA was allowed to proceed for 12 hours at
room temperature, then, exposed sulphydryl groups on the protein were
alkylated by adding 0.3M iodoacetate (Sigma). This prevented the
spontaneous re-folding of the molecule. The mixture was left stirring
at room temperature for 2 hours during which time pH7 was maintained
by the addition of NaOH. The protein was then dialysed against large
volumes (about 2 litres) of 0.05M Na^ HPO^ and then against
phosphate-buffered saline, PBS. The resultant solution was filter
o
sterilised using a 0.2pm millipore filter and stored at 4 C.




dissolved in distilled water to a final volume of 1 litre.
pH 7.2
Deaggregated OVA was prepared according to the method of Colby and
Strejan (1980): a solution of OVA in distilled water (5 mg/ml) was
centrifuged for 3 hours at 100,000 g in a Beckman Spinco (Model L)
ultracentrifuge. the top one-third of the solution was then collected
and injected into the mice on the same day, as deaggregated OVA tends
to spontaneously re-aggregate.
Anaesthesia
All procedures with BDF1 mice were carried out using light ether
anaesthesia. BALB/c mice were anaesthetised for footpad injections
and blood collections.
Injections
Intra-venous (i.v.) injections in mice were made via the
retro-orbital venous plexus using a 26 gauge needle.




Mice were immunized with- 100 ^ig antigen emulsified in Freund's
complete adjuvant or FCA (H37Ra, Difco) and injected intradermally
into one rear footpad (injection volume, 0.05 ml) using a 26 gauge
needle.
Feeding Procedure
Mice were fed with antigen or control solutions by intragastric
intubation using a 19 gauge stainless steel dosing needle with a
rounded tip. ■ For oral tolerance induction, mice were fed without
previous fasting, with 25 mg OVA dissolved in 0.2 ml of either sterile
water or sterile physiological saline (0.15M NaOH).
Blood Collection
Up to 200 ji1 of blood were obtained routinely from the
retro-orbital plexus under ether anaesthesia using heparinised
haematocrit tubes (Propper Ltd, Long Island, New York). This route
was chosen for survival experiments. Larger quantities of blood were
obtained by either cardiac puncture or bleeding mice from the axillary
vessels. Haematocrit tubes were sealed with CRISTASEAL (Hawksley,
England) and allowed to clot in the upright position before being spun
in a haematocrit centrifuge (Hawksley, England) for five minutes.
Sera obtained for testing in haemagglutination assays were
decomplemented for 30 minutes in a water bath at 56°C. All sera were
stored at -20°C.
Weighing Mice
Mice were weighed on an Oertling TD30 top pan balance.
Cyclophosphamide Treatment
Mice were weighed and then injected i.p. with 100 mg per kg body
weight cyclophosphamide or CY (Endoxana) dissolved in sterile water.
Irradiation of Mice
Mice were placed inside a perpex jig. They were irradiated at a
rate of 38 rads per minute and received a total dose of 1,000 rads
from a 250 megavolt orthovoltage x-ray source (Siemens Orthovolt).
This procedure was very kindly carried out by Mrs Barbara Clarke
and Miss Sandra Biggar, Radiation Oncology Unit, The Western General
Hospital, Edinburgh.
Spleen Cell Reconstitution
Spleens were removed from BDF1 mice which had been killed by
cervical dislocation. A suspension of spleen cells in RPM1 1640
medium (Flow Laboratories Ltd), was prepared by cutting the spleens
into tiny pieces with fine scissors and then forcing the tissue
through a fine mesh metal strainer using the plunger of a 5 ml
disposable syringe. The suspension was sucked up and down in a
syringe to disperse any clumps before the cells were washed and
counted. Cells were counted in an improved Neubauer haemacytometer
slide chamber using Trypan Blue Dye exclusion as a means of
identifying viable cells from the total number of cells which was
estimated using white cell diluting fluid. The concentration of
g
viable cells was adjusted to 5 x 10 cells per ml and recipient
g
animals were injected i.v. with 0.05 ml (25 x 10 cells) of the
suspension.
Assessment of Systemic Delayed-Type Hypersensitivity
Mice were tested for delayed-type hypersensitivity (DTH) with
microcalipers (P0C0TEST-A, Carobronze Limited, London, United Kingdom)
by measuring the increment in footpad thickness 24 hours after an
intradermal injection of 100 pg of antigen in 0.05 ml of saline into
the plantar side of a non-immunised rear footpad. Control mice were
challenged with saline. The increment in footpad thickness in
response to saline was almost always zero or less than zero.
Passive Haemagglutination Assay
In some experiments, sera were tested for antibodies by passive
haemagglutination. Sheep red blood cells were collected and stored in
Alsever's solution* and washed three times in saline at 150 x g
before use. 100 packed sheep red blood cells were mixed with 0.7
ml saline and 100 pi protein solution (15 mg/ml ovalbumin) in saline.
1 ml of 0.01% chromic chloride (Analar, BDH Limited) in saline at pH
5.0 was added dropwise under continuous agitation. The mixture was
then allowed to stand for 10 minutes at room temperature (around 25
C). The reaction was stopped by adding 10 ml of PBS and the coated
cells were then washed twice in PBS and resuspended at 1% before use.
Decomplemented sera were absorbed with 10% sheep red blood cells
for about one hour before use. 25 serum was doubly diluted with
physiological saline in round bottom microtitre plates (TITERTEK, Flow
Laboratories) and 25 Z11 of coated sheep red blood cells were added
with a multi channel (eight) pipette (TITERTEK, Flow Laboratories) to
each well.
After settling for 90 minutes at room temperature, the titres
were taken as the last dilution to show complete agglutination. All
sera were tested with or without the addition of 25 pi of 0.1 M
2-mercaptoethanol (Sigma Chemical Co Ltd) to obtain information on




Na CI 4.2 g
sodium citrate 8.0 g
sterilised by membrane filtration (0.2 p.m)
stored at room temperature.
Detection of Anti-ovalbumin Antibodies in Mouse Serum Using An
Enzyme-Linked Immuno-Sorbent Assay (ELISA).
(i) ELISA REAGENTS
Carbonate buffer; 0.05 mol/litre at pH 9.6 (Northeast
Biomedicals Ltd).
Washing solution; 0.05% Tween 20 (BDH) in physiological saline.
Serum Diluent; 0.05% Tween 20 in physiological saline with 0.2%
sodium azide (BDH).
Substrate buffer; 100 ml DEA (diethanolamine; BDH)
800 ml H20
0.1015 g Mg CI . 6H20 (BDH)
0.2 g sodium azide
pH 8.6
(ii) ELISA FOR ANTI-OVA ANTIBODIES
This assay was developed by Dr Stephan Strobel and Mrs Margaret
Gordon. Mrs Gordon also carried out these assays in my experiments.
OVA was dissolved in carbonate buffer at a concentration of 1 mg/ml
and 125 pi of this solution was added to each well of a microtitre
plate (Linbro; Flow Laboratories Ltd) and incubated for 16 hours
(overnight) at 4° C. All incubations were carried out in a moist box
to prevent "edge effects". The wells were then washed 3 times with
ELISA washing solution.
Mouse sera to be tested, including hyperimmune mouse reference
serum as a positive control, were diluted 1 in lOOin serum diluent and
added in 125 jil volumes to the wells. The plate was incubated at room
temperature for 5 hours and then washed 3 times with ELISA washing
solution.
A dilution of 1 in 1750 in serum diluent of rabbit anti-mouse IgG
conjugated to alkaline phosphatase (Miles-Yeda Ltd) was added to each
well in 125 ^il volumes. The plate was incubated for 16 hours at room
temperature and then washed 3 times as before.
Substrate solution was added (1 mg/ml -jp-nitrophenyl phosphate;
Sigma 104 phosphatase substrate tablets in substrate buffer), 125 yjl
per well, and incubated for approximately 30 minutes at room
temperature. The plate was then read using an automatic ELISA reader
(Dynatech Ltd) set at wavelength 405 nm.
Detection of anti-HSA Antibodies in Mouse Serum by ELISA
HSA was dissolved, 15 mg/ml in carbonate buffer and 125 jul of
this solution was added to each well of a microtitre plate. The plate
was incubated for 16 hours (overnight) at 4°C and then washed 3 times
with ELISA washing solution.
Reference and test sera were diluted 1 in 100 in serum diluent
and added in 125 ul volumes to the wells. The plate was incubated at
room temperature for 2 hours and then washed 3 times with ELISA
washing solution.
A dilution of 1 in 1750 in serum diluent was made of the rabbit
anti-mouse conjugate (used for the anti-OVA ELISA) and 125 ul added to
each well. This was followed by a 3 hour incubation at room
temperature.
The plate was washed 3 times with ELISA washing solution and then
125 p.1 substrate solution was added to each well. After an incubation
of approximately 35 minutes at room temperature, the plate was read at
wavelength 405 nm.
This assay was developed and performed by Mrs Margaret Gordon.
Detection of OVA in Mouse Serum by ELISA
Acrylic microtitre plates (Falcon; Becton and Dickinson) were
coated with 150 y.1 of specifically-purified IgG anti-ovalbumin
antibody (the generous gift of Dr Donald G. Hanson) diluted in
carbonate buffer (10 jig/ml) for 2 hours at 37° C. After this
incubation, plates were washed 3 times with ELISA washing solution.
Standard concentrations of OVA were obtained by making logwise
dilutions of OVA in normal mouse serum and were diluted a further 1 in
10 in serum diluent before being added to wells in 125 Jil volumes.
Plates were incubated for 16 hours (overnight) at room
temperature and then washed 3 times with ELISA washing solution.
Conjugate (Rabbit IgG-anti-OVA coupled to alkaline phosphatase;
Northeast Biomedicals) was diluted 1 in 500 in serum diluent and 125
^il added to each well. Plates were incubated at room temperature for
24 hours and then washed 3 times with ELISA washing solution.
Substrate solution was then added, 125 h1 per well, and the plates
were read at wavelength 405 nm.
This assay was developed by Mrs Barbara Walton and performed in
my experiments by Mrs Hazel Drummond.
Collection of Samples for Histology-
Mice were killed by cervical dislocation. Immediately afterward,
pieces of jejunum about 5 mm long were removed at 10 cm from the
pylorus, placed on a piece of card and cut open. The cards were
placed in about 10 ml of fixative.
Fixing and Staining Histological Specimens
Samples for conventional histology were fixed in 10% buffered
formalin and embedded in paraffin wax. Sections 5 microns thick were
cut and stained with haematoxylin and eosin.
Histological processing was carried out by Mr Alexander
Sutherland.
Intraepithelial Lymphocyte Counts
Intraepithelial lymphocyte counts are expressed as the number of
intraepithelial lymphocytes/100 villus epithelial cells. Sections
were examined under x 1000 (oil immersion) magnification and only well
cut sections with a single epithelial cell layer were counted.
Counts were done by enumerating epithelial and lymphoid cell
nuclei lying unequivocally above the basement membrane and a total of
500 cells were counted in each specimen. In serially sectioned
specimens care was taken to avoid recurring areas.
Measurement of Intestinal Villi and Crypts
Pieces of jejunum were fixed in Clarke's fixative for maximum 24
hours. Thereafter they were transferred to 75% ethanol for storage
before microdissection. To allow repeated examination in case of
technical difficulties, only half of the tissues were stained in bulk
by the modified Feulgen reaction. Pieces of gut were immersed in 50%
ethanol for 10 minutes, followed by tap water for 10 minutes and 7
o
minutes hydrolysis in 0.1 N HC1 at 60 C. The tissue was then rinsed 3
times with tap water and stained with Schiff reagent (Difco Limited)
for 20-30 minutes at room temperature and then kept in tap water
(maximum 48 hours) for microdissection.
The lamina muscularis mucosa was removed under the dissecting
microscope (x32, Zeiss Stereomicroscope 4B) and a single villus or
thin segments of mucosa containing a few villi and their crypts were
then cut out of the non-traumatised mucosa by dissection with a
cataract knife (Weiss Limited). The mucosal fragments were placed on
a slide in a drop of 45% acetic acid, covered with a coverslip and
examined under a microscope with a previously calibrated eyepiece
micrometer.
In each specimen, the lengths of 10-15 complete villi and crypts
were measured and the means taken for group comparisons.
Counts of intraepithelial lymphocytes and measurements of
intestinal villi and crypts were performed in collaboration with Dr
Stephan Strobel.
Fixatives Used in Histology
(i) 10% buffered formalin (1 litre):.
Formalin (40% formaldehyde) 100.0 ml
H20 900.0 ml
Na2 HP04.2H20 4.0 g
Na
2 HP04 6.5 g
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(ii) Clarke's fixative (1 litre)
ethanol (96%) 750.0 ml
glacial acetic acid 250.0 ml
Statistical Analysis and Presentation of Data
In general, results are presented as means +1 standard error of
the mean (s.e.) or +1 standard deviation (s.d.) as stated in figures
and tables.
Students t-test was used to compare differences between group
means in most cases. Where between-group comparison by t-test was
innappropriate has been indicated in tables by a dash (-).
Antibody levels measured by ELISA are expressed as units of
optical density at 405 nm and were compared by Wilcoxon Rank Sum tests
since non-parametric distribution of this data could not be ruled out.
P values of greater than 0.05 are indicated as N.S. (not
significant).
Results which were below the levels of detection of an assay are
described either as "below background" as in the case of lymphocyte
transformation tests, or "negligible" (neg.) as in the ELISA to detect
OVA in serum.
*
Calculations were done using either a Sharp EL-58A or a Casio
fx-3600P calculator.
Plates A and B
DTH response to OVA elicited in the footpad 21 days after
OVA immunization.
A : pre-DTH challenge, footpad thickness = 1.8mm
B : 24 hours after DTH challenge, footpad thickness = 1.9mm
Plate C
DTH response to OVA elicited in the footpad 21 days after
OVA immunization.
Upper footpad : 24 hours after saline challenge
Lower footpad : 24 hours after OVA challenge
SECTION (b)
DEVELOPMENT OF AN ANTIGEN-DRIVEN MOUSE T CELL TRANSFORMATION ASSAY
Introduction
This assay was developed based on the in vitro lymphocyte
migration inhibition assay of Mowat and Ferguson, (1981)a, and the
mouse T lymphocyte transformation assays of Corradin et al (1979), and
of Kagan and Ben-Sassoon (1980). There were 3 basic stages in the
development of this assay:
(i) Determination of the concentration of radio-labelled
Thymidine, cell number and mitogen dose for non-specific
transformation;
(ii) Determination of the optimum cell number and antigen dose
for OVA-specific transformation;
(iii) Confirmation of the T cell-dependency of OVA-specific
transformation.
In this section I shall first of all describe the assay and then the
experiments leading to its development.
Mouse T Lymphocyte Transformation Assay Medium
4
The culture medium consisted of RPMI 1640 medium (Flow
Laboratories Ltd) supplemented with 2 m.mol/1 glutamine (Flow
Laboratories Ltd), 100 I.U./ml Penicillin and 100 ^ig/ml Streptomycin
(Flow Laboratories Ltd), 50 /U.mol/1 2-mercaptoethanol (Sigma), 5%
human AB+ serum (a generous donation from Dr B MacLelland, Edinburgh
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and S.E. Scotland Regional Blood Transfusion Service) and buffered
with 10 m mol/1 HEPES buffer at pH 7.2 (Flow Laboratories Ltd).
Antigen and Mitogen
Ovalbumin or OVA (egg albumin, Grade V, Sigma) was used at a
and the T cell mitogen Phytohaemagglutinin or PHA (Wellcome) used at a
concentration of 0.45 mg/ml in cultures.
Preparation of a Lymphocyte Suspension
Mice were killed by cervical dislocation and pinned out on a cork
dissecting board which had been swabbed with alcohol. Mice were also
swabbed before dissection to prevent loose fur from contaminating the
cell preparation. Whenever possible, separate sets of sterile
instruments were used for cutting open the skin and for removing the
lymph nodes. From mice which were consistently immunized in the right
hind footpad, were removed the right popliteal and inguinal lymph
nodes and when necessary, the mesenteric lymph nodes. These were
trimmed of excess fat before being placed in a sterile petri dish
containing a little medium.
Lymph nodes were teased with fine scissors and then forced
through a fine mesh metal strainer using a 5 ml disposable syringe
plunger. The resultant cell suspension was sucked up and down in a
syringe, in order to disperse any clumps, and then transferred to a
sterile universal bottle which was topped up with fresh medium.
The suspension was washed 3 times in fresh medium by
centrifugation at 400 g for 7-10 minutes per wash in either an MSE
Super Minor or MSE Multex centrifuge. After the final wash, the
concentration of 1.25 mg/ml, that is,
number of viable cells in the suspension was estimated by subtracting
the number of cells staining with Trypan Blue dye from the total
number of lymphocytes, stained with white cell diluting fluid. Cells
were counted on an Improved Neubauer haemacytometer slide using a
Leitz Ortholux microscope. The concentration of viable cells was
6
adjusted to 2.5 x 10 ' cells/ml in culture medium containing antigen or
mitogen where appropriate.
Treatment of Cells with Anti-Thy 1.2 and Complement
A suspension of lymph node cells, were prepared and counted.
0
Cells were suspended at a concentration of 10 x 10 cells per ml in 5
ml anti-Thy 1.2 (F7DF monoclonal IgM, cytotoxic antibody; OLAC 1976
Ltd) diluted 1 in 1 000 in RPMI 1640 and left for 30 minutes at room
temperature. After this incubation, 5 ml complement (fresh guinea pig
serum diluted 1 in 5 in sterile saline) was added to the suspension
and this was incubated a further 40 minutes at 37 °C.
The cells were then re-counted, washed once and re-suspended in
6
fresh culture medium at a concentration of 2.5 x 10 cells per ml.
Control samples included untreated cells and cells treated with
complement only. The controls were subjected to the same incubation
times and temperatures as the test samples.
Culturing Cells
Cultures were set up according to experimental protocol, in
quadruplicate wells containing a total volume of 200 each in
sterile, 96-well, flat-bottomed Microtiter plates of tissue culture
grade with lids (Flow Laboratories Ltd). The culture plates were
handled and opened only inside a Micrcflow cabinet (Microflow Ltd)
with uni-directional air flow. Cultures were incubated in a Hotpack
humidified CO^ incubator at 37°C with 80% humidity in a mixture of 5%
COg and 95% air. The day of setting up a culture was called day 0.
Radio-Labelling Cultures
On day 4 of culture, the cells were pulsed with 0.01 jiCi per well
14
of C -labelled Thymidine (Amersham International) diluted in sterile
saline. Some wells were always left unlabelled as controls for
machine background radiation counts.
Harvesting Cultures
On day 5, at 18-20 hours after pulsing, the cells were harvested
onto Titertek filter paper discs (Flow Laboratories Ltd) using an
automated cell harvester (Dynatech Automash). The discs were allowed
to dry thoroughly and were then placed in plastic minivials
(Scintillation mini vials, A & J Beveridge Ltd) inside glass
scintillation vials (A & J Beveridge Ltd). These were filled with 2.5
ml Koch-lite scintillation liquid (A & J Beveridge Ltd) inside a
fume-hood and sealed.
14
C - Thymidine uptake was measured as counts per minute (cpm)
using a Packard Tri-Carb Liquid Scintillation Spectrometer which
measured p emission. The counting efficiency of the machine was
checked by comparing the cpm obtained from a filter disc labelled with
a standard 0.01^uCi with the formula!
0
I^iCi = 2.2 x 10 disintegrations per minute. During the period
of time when these assays were being performed, the counting
efficiency of the machine was 50%.
Data Handling
The mean background cpm was calculated and subtracted from all
counts before the mean cpm of quadruplicate wells was calculated. A
stimulation index (SI) was calculated where appropriate from the
formula:
SI = mean cpm of stimulated wells
mean cpm of unstimulated wells
14
Determination of C -Thymidine Concentration, Optimum Cell Number and
Mitogen Dose For Non-Specific Transformation
Test cultures were set up using lymph node cells from naive BDFI
I
mice. In one culture, an arbitrary cell concentration of 2 x 10
cells per well was chosen and the cells were either left unstimulatd
or were stimulated with 0.45 mg/ml PHA. The cells were labelled, on
14
day 4 with either 0.1 uCi or 0.01 fJiCi C -Thymidine.
From the results of these tests (Table (a)) it was found that as
, • , 14little as 0.01 pCi 0 -Thymidine added to PHA-stimulated cells could
produce high counts against a very low background of cpm in labelled
unstimulated cells. This concentration of isotope was then adopted
for use in every subsequent assay.
In a second culture, the response of various numbers of cells to
PHA was tested including the response to PHA employed at the 5 times
higher dose of 2.25 mg/ml. The optimum response was seen when the
lower dose of PHA, 0.45 mg/ml, was used and for all cell
concentrations, with a slightly better response occurring in the range





















PHA-Response of Naive Lymph Node Cells Detected By Two Doses
14
of C -Thymidine
Cells were obtained from BDFI mice. Cultures were labelled with
14






Mean cpm + s.e.
5
5 x 10 cells 2.25 696 + 418
5
5 x 10 cells 2.25 2,795 + 756
5
4 x 10 cells 2.25 2,363 + 270
5
3 x 10 cells 2.25 880 + 115
5
6 x 10 cells 0.45 4,243 + 1,054
5
5 x 10 cells 0.45 6,922 + 1,345
5
4 x 10 cells 0.45 8,339 + 596
5
3 x 10 cells 0.45 5,765 + 2,063
TABLE (b)
PHA-Response of Naive Lymph Node Cells
Cells were obtained from BDFI mice.
5
A range of numbers of cells from 3 - 6 x 10 was tested in LTT.
PHA was used at 2 doses: 2.25 mg/ml and 0.45 mg/ml.
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Determination of the Optimum Cell Number and Antigen Dose For
OVA-Specific Transformation
A second set of test cultures were set up, this time using cells
from lymph nodes draining the footpads of BDFI mice immunized 21 days
previously with 100 yog OVA in FCA. Experiments on the DTH response of
these mice had shown a peak of responsiveness 21 days after
immunization.
In the first of these tests, the range of cell concentrations
5 5
which had been found to respond well to PHA, that is 3 x 10 , 4 x 10
5
and 5 x 10 cells per well, were tested against a range of doses of
OVA, from 100 yjg - 1 pg per well and the results are summarized in
Table (c).
It was apparent from the lack of response, that despite the
responsiveness of cells to a very low dose of a non-specific T cell
mitogen, PHA, the antigen-specific response required a higher
concentration of OVA before the OVA-specific population could respond.
The only indication of a response to OVA in this dose range was
5
when the cells were at a concentration of 5 x 10 cells per well and
so I decided to test this concentration first. In this culture, I
5
tested the rsponse of 5 x 10 OVA-primed cells to a range of OVA
concentrations between 10 jxg and 1 000 jig per well and included a
PHA-stimulated positive control. The results given in Table (d)
produced a dose-response curve, which is shown in figure (a), with the
optimum response to 250 jig OVA per well. I decided to utilise these
optima for all subsequent cultures.
Confirmation of the T Cell-Dependency of OVA-Specific Transformation
In order to ensure that the lymphocyte transformation assay was a
Cells Per Well ^g OVA Per Well Mean cpm + s.e.
5 x 105 100 257 + 81
5 x 105 50 6.3 + 7
5 x 105 10 93 + 71
5 x 105 22 + 18
5
5 x 10 0 10, 8 (n = 2)
4 x 1C5 100 25 + 21
'
4 x 105 50 17 + 9
4 x 10° 10 17 + 9
4 x 10^ 1 13 + 3
4 x 105 0 7, 45 (n = 2)
3 x 105 100 below background
3 x 105 50 13 + 3
3 x 10D 10 below background
3 x 10 1 below background
3 x 105 r\U 1*2
TABLE (c)
Response of OVA-primed lymph node cells to OVA.
Cells were obtained from BDFI mice 21 days after immunization with OVA.
5
3, 4 or 5 x 10 cells were tested in LTT with a range of OVA doses as
shown.
The response in wells without added OVA are expressed as individual




5 x 10 cells Mean cpm + s.e. Stimulation Index
Nothing 158 + 75 1
0.45 mg/ml PHA 8,269 + 822 20.6
1,000 fig OVA 797 + 240 5
750 ^Ug OVA 1,246 + 210 7.9
500 yug OVA 1,432 + 233 9.1
250 fag OVA 1,820 + 298 11.5
100 fig OVA . 1,155 + 168 7.3
50 fig OVA 755 + 33 4.8
10 yug OVA 222 + 26 1.4
TABLE (d)
5
Response of 5 x 10 OVA-primed Lymph Node Cells To OVA
Cells were obtained from BDFI mice 21 days after immunization
with OVA.
5












Response of 5 x 10 OVA-primed lymph node cells to a range of doses of OVA.
Results are mean cpm + s.e.. For responses in the dose range 10 jag
- 250 yig, r = 0.97. For responses in the dose range 250 pg - 1000 ^ig,
r = 0.97.
Cells were obtained from BDFI mice 21 days after immunization with OVA.
measure of antigen-stimulated T cell proliferation and to test that
OVA was not behaving simply as a T cell mitogen, I performed a set of
assays where in one case, T cells were removed from an OVA-primed
lymph node population by incubation with anti-Thy 1.2 and complement
as described at the beginning of this section.
In a second test, I examined the OVA-specific response of cells
taken 3 weeks after a sham-immunization of saline in incomplete
Freund's adjuvant. This illustrated the response of non-immune cells,
with respect to OVA.
The absence of a response in the T-depleted lymph node cells
(Table (e)) reveals the T cell dependency of the lymphocyte
transformation assay. Removal of T cells effectively removed the
response to OVA.
Finally, Table (f) illustrates that non-immunized mice do not
respond to OVA per se and so I concluded that the assay effectively
measured the T cell-dependent proliferation of OVA-primed cells in
response to that specific antigen.
Culture Cell Stimulation
Containing Pre-treatment Mean cpm + s.e. Index
Cells only none 16 + 5 1
PHA none 1,975 + 176 123.4
OVA none 397 + 36 24.8
Cells only C, only 11 + 9 1
PHA C, only 1,067 + 687 97
OVA C, only 103 + 69 9.4
Cells only anti-Thy 1.2 + C 8 + 4 1
PHA anti-Thy 1.2 + C 22+4 2.8
OVA anti-Thy 1.2 + C 9+3 1.1
TABLE (e)
5
Response of 5 x 10 OVA-primed lymph node cells to OVA and PHA:
Effect of depleting T Cells.
Cells were obtained from BDFI mice 21 days after immunization
with OVA.
T Cells were depleted from lymph node cell populations by treatment
with anti-Thy 1.2 plus complement (C) as described in Chapter 2,
Section (a). _
Added to Stimulation
Culture Mean cpm + s.e. Index
Nothing 8 + 4 1
PHA 613 + .126 76.6
250 yg OVA 14 + 6 1.8
TABLE (f)
0
OVA and PHA Response of 5 x 10 Lymph Node Cells From
Mice Sham-Immunized with Saline in Incomplete Freund's
Adjuvant.
BDFI mice were injected with 0.05 ml of a 1 : 1 emulsion
of saline in adjuvant.
Cells were obtained 21 days after injection.
SECTION (c)
IMMUNOCHEMICAL TECHNIQUES
A. Preparation of Immunoadsorbent anti-OVA Antibodies Coupled to
Sepharose (S4B-anti-0VA)
Anti-OVA Antibody
The source of anti-OVA antibodies was a rabbit anti-OVA
hyperimmune antiserum (the generous gift of Dr Allan Mowat). The
antiserum formed a single precipitin line in the presence of OVA
antigen and 16% of the immunoglobulin (Ig) was specific anti-OVA. The
Ig portion of the antiserum was isolated by repeated precipitation
with a saturated ammonium sulphate solution and had a total protein
content of 6.6 mg/ml. If 16% of this was anti-OVA antibody then the
concentration of anti-OVA antibody in the Ig preparation was
approximately 1 mg/ml.
Coupling Procedure
Anti-OVA Ig was coupled to Sepharose 4B (Cyanogen
bromide-activated; Pharmacia Fine Chemicals) according to the
manufacturer's recommendations laid out in their pamphlet "Affinity
Chromatography". Briefly, the Ig preparation was dissolved in protein
coupling buffer (NaHCO^ (BDH), 0.1M, pH 8.3 containing NaCl (BDH),
0.5M) and added to Sepharose 4B gel (S4B) to a final concentration of
5 mg protein per mi of gel and mixed in an end-over-end mixer for 2
hours at room temperature. Excess protein was then washed away with
fresh coupling buffer and the gel was mixed with ethanolamine solution
(Ch (OH)CH^ (BDH), IM, pH 9) for 2 hours at room temperature in
order to block any remaining active sites on the S4B beads.
The gel was washed three times; first with coupling buffer, then
with acetate buffer (0.1M pH , containing NaCl, 0.5M) and finally with
coupling buffer. The final product was stored at 4°C in PBS containg
0.2% sodium azide as a preservative.
Acetate buffer (1,000 ml):
CHgCOONa (BDH) 0.1N 16.6 ml
CH3C00H (BDH) 0.IN 83.4 ml
In preparing S4B-anti-0VA, 2.65 ml of the Rabbit Ig was used to couple
with 3.5 ml of S4B. Therefore 2.65 mg of anti-OVA Ig was added.
According to the manufacturer's guidelines, the coupling procedure
should be 90% efficient. This means that 2.4 mg of anti-OVA Ig (90%
of 2.65 = 2.4) was coupled to 3.5 ml S4B. The concentration of
anti-OVA Ig bound to S4B was therefore 690 yag per ml of S4B.
Binding Capacity of S4B-anti-0VA
In order to determine the OVA-binding capacity of the
S4B-anti-0VA, 500 ^il of a constant concentration of OVA (10 ^ig/ml)
dissolved in normal mouse serum was added to increasing volumes of
S4B-anti-0VA which was mixed for 4 hours at room temperature.
After this time, the S4B-anti-0VA was allowed to settle and the
supernatant containing any unbound OVA was removed and tested for OVA
concentration in the ELISA described in Chapter 2. The amount of OVA
which remained bound to the S4B-anti-0VA was estimated using a "bead
ELISA" which was developed by Mrs Hazel Drummond:
"Bead ELISA"
After incubation with OVA as above, the S4B-anti-0VA was washed 3
times in 5 - 10 ml ELISA washing solution by suspending the beads in
the solution, allowing them to settle and removing the supernatant.
The immuno-adsorbent beads were then mixed for 4 hours at room
temperature in 0.1 ml of a 1 in 250 dilution of rabbit anti-OVA IgG
conjugated to alkaline phosphatase (see Chapter 2, ELISA for OVA).
The supernatant was removed and the beads were once again washed
3 times with ELISA washing solution. ELISA substrate solution (1 ml)
was then added and the beads were mixed with this until the coloured
reaction product had developed. Aliquots of bead supernatant
containing the colour were removed into an ELISA plate and read in the
automatic ELISA reader at wavelength 405 nm.
The results (summarized in figure (b) and Table (g)) show that as
the amount of S4B-anti-0VA was increased relative to a fixed amount of
OVA, the amount of OVA left unbound in the supernatant decreased and
the amount of OVA bound to S4B-anti-0VA showed a corresponding
increase.
After mixing 500 yul of 1 Ojj,g/ml OVA with 200 yal S4B-anti-0VA,
only 18 ng OVA remained in the supernatant of the original 5000 ng
added. This meant that 200 yul S4B-anti-0VA had effectively bound 4982
ng OVA, approximately 5 yag. In my experience, the concentration of
OVA found in serum 1 hour after a feed of 25 mg was usually of an
order of 10 ng and so I chose to use 200 yal of S4B-anti-0VA, with a
binding capacity for approximately 5 ;ug OVA in my subsequent
immune-adsorption studies.
FIGURE (b)
OVA bound to S4B-anti-0VA detected by "bead" ELISA expressed as
O.D. 405 nm.
Increasing amounts of IgG anti-OVA coupled to Sepharose 4B were
added to 5 pg OVA. The amount of OVA bound by the Sepharose beads
increases as more beads are added.
Volume of
S4B-Anti-OVA O.D. 405 nm OVA per ml
50 pi (i) 0.714 1.8 /ug
50 pi (ii) 0.668 0.9 pg
100 pi (i) 0.340 234 ng
100 pi (ii) 0.302 200 ng
150 pi (i) 0.071 45 ng
150 pi (ii) 0.065 40 ng
200 pi (i) 0.055 35 ng
200 pi (ii) 0.052 38 ng





OVA (by ELISA) In Supernatants After S4B-Anti-0VA Treatment
Increasing volumes of S4B-Anti-0VA were added to 500 pi normal
mouse serum containing 5 pg OVA. Each sample was run in duplicate.
The test included a "blank" containing only ELISA substrate, a
"conjugate blank" containing rabbit anti-OVA IgG conjugated to
alkaline phosphatase plus ELISA substrate, and a sample of normal
mouse serum (NMS). The amount of OVA remaining in supernatant
decreases as more S4B-Anti-0VA is added.
B. Standardisation of a Gel Filtration Column
Equipment and Running Conditions
Serum proteins were fractionated by gel filtration through a
column of Sephacryl S200, Superfine (Pharmacia Fine Chemicals)
which separated proteins on the basis of molecular weight.
The column was a Wright glass column which was 60 cm long with
internal diameter 22 mm (Amicon). According to the manufacturer's
guidelines for the use of Sephacryl, the column was packed with S200
in 0.25M NaCl with 0.2% sodium azide. The sodium chloride gel buffer
was de-gassed before use.
After packing, the total volume of gel in the column, the bed
volume, was 151 ml. Samples of between 3% and 4% of this volume
(about 5 ml) were routinely applied to the base of the column and
passed upwards through the gel at 1.4 ml/minute by means of a
peristaltic pump. Fractions coming off the column were continuously
monitered by a "flow-through" spectrophotometer (LKB Uvichord II) set
at 208 nm wavelength and connected to a recorder (Servoscribe, Belmont
Instruments). Fractions of 3 ml were collected sequentially in an LKB
2070 Ultrorac II fraction collector.
Calibration of the Column
The column was calibrated using a mixture of molecules of known
molcular weights. The void volume (Vo) of the column was determined
by applying Blue Dextran to the column. This large molecule
(Molecular Weight = 2,000,000) is not retained by Sephacryl beads
which exclude molecules of weight greater than 250,000 and appears in
the volume of buffer flowing ahead of the filtered sample.
The calibration mixture contained:
Column Buffer 5ml
Blue Dextran (Pharmacia) MW = 2,000,000 lmg
Ovalbumin (Sigma) MW = 43,500 100 mg
Cytochrome - c (Sigma) MW = 12,400 5 mg
glycyl tyrosine (Sigma) MW = 238 10 mg
The di-peptide glycyl-tyrosine was eluted last from the column
and its elution volume was considered the total working volume (Ve) of
the column. The elution profiles of these standards are shown in
figure (c). The elution volume (Ve) of each standard was used to
calculate a distribution coefficient Kav from the formula:
Kav = Ve - Vo
Vt - Vo
Kav represents the fraction of the gel volume which is available for
diffusion of a given solute species and should therefore have a linear
relationship with molecular weight. When Kav was calculated for each
standard and compared to molecular weight by linear regression
analysis a correlation co-efficient of r = 0.93 was found. This demonstrates
a good linear relationship between Kav and log.^^ molecular weight, and
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FIGURE (c)
Calibration of gel filtration column.
Standard solutions of Blue Dextran (BD), OVA, cytochrome-c (cyt-c)
and glycyl tyrosine (gly-tyr) were used to calibrate the column.
Elution volumes illustrate where peak protein concentrations are




STUDIES in vitro OF IMMUNE
REGULATION BY ANTIGEN
FEEDING
SECTION (a)'. THE INDUCTION OF SYSTEMIC TOLERANCE TO OVALBUMIN BY
FEEDING
3.1 Introduction
It had been previously demonstrated in this laboratory that a
single feed of 25 mg OVA caused suppression of subsequent immune
responses to OVA in BALB/c mice and that tolerance to OVA induced in
this manner is CY-sensitive, indicating the involvement of suppressor
T cells in its mechanism (Mowat et al, 1982). When the CY-sensitive
mechanism is removed prior to OVA feeding, a local cell-mediated
immune response to OVA is induced in the small-intestinal mucosa and
the mesenteric lymph nodes (Mowat and Ferguson, 1981 a).
These experiments were performed either in vivo or by assaying
the in vitro inhibition of lymphocyte migration as a test for
cell-mediated immunity. My research aim at this stage was to study
cellular interactions associated with the induction of oral tolerance
and so I utilised in vitro antigen-driven transformation of
lymphocytes as a test for local cell-mediated immunity.
I followed the hypothesis that removal of a CY-sensitive
suppressor mechanism led to the abrogation of oral tolerance to
subsequent antigen feeding and permitted the induction of
cell-mediated immunity in the gut. I reasoned that the mesenteric
lymph nodes of such animals should contain activated lymphocytes
capable of transforming in vitro in response to OVA. If such a
cellular immune response was identified it could then be analysed and
characterised further.
Having established a mouse lymphocyte transformation test or LTT,
as an in vitro assay of T cell-dependent antigen-induced stimulation
of primed lymph node cells (Chapter 2, Section (b) ), I first of all
repeated standard in vivo experiments to show the induction of oral
tolerance to OVA and its abrogation by CY injected prior to OVA
feeding. In parallel with these experiments, I assessed the LTT as an
assay for systemic cell-mediated immunity, its suppression by antigen
feeding and the effect of CY on that suppression.
In a second set of experiments, described in section (b) of this
chapter, I studied in more detail the kinetics of the in vitro
response to OVA of cells in the mesenteric lymph nodes of CY-treated
mice by assaying lymphocyte transformation to OVA at various times
after feeding a single tolerizing dose of OVA to CY-treated mice.
Separate experiments were also set up to assess lymphocyte activation
in peripheral and mesenteric lymph nodes on different days following
OVA feeding, again with a single tolerizing dose of OVA.
3.2 Design of Experiments
Groups of BDFI mice were treated according to the experimental
protocol in figure 1 and fed on day 0 of the experiment with either
0.2 ml physiological saline (Group 1) or 25 mg OVA (Group 2) by
intragastric intubation. A third group was injected i.p. with 100
mg/kg CY on day -2, that is 2 days before being fed 25 mg OVA (Group
3). One week after feeding, on day 7 of the experiment, all mice were
given a primary immunization with 100 jig OVA in Freund's complete
adjuvant (FCA) and 3 weeks after immunization, serum anti-OVA
antibodies were measured using a haemagglutination assay. Antibody
which was sensitive to mercaptoethanol dissociation was classed as IgM
and non-sensitive as IgG. The same mice were also tested for delayed
hypersensitivity by skintesting with antigen in the footpad and
measuring the 24 hour increment in footpad thickness.
For the parallel in vitro experiment, groups of mice were treated
according to the same experimental protocol. Three weeks after
immunization they were killed and cells from mesenteric (MLN) and
peripheral (popliteal and inguinal) lymph nodes (PLN) were prepared
for 5 day cultures. Cultures consisted of quadruplicate wells
5
containing 5 x 10 cells in supplemented RPMI 1640 medium to which
were added either a T cell mitogen, phytohaemagglutinin (PHA) as a
control to show positive transformation, or 250 )ig OVA or nothing.
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The cultures were labelled on day 4 with 0.01 ^iCi C -thymidine and
harvested on day 5 for jp-scintillation counting. In every culture, 4
spare wells were not labelled and were used to determine background
radiation which was subtracted from the counts per minute (cpm) in
labelled wells. The mean cpm was calculated and a stimulation index
obtained by dividing the mean cpm of PHA or OVA-containing wells by
that found in unstimulated wells. Students t-test was used to compare
quadruplicates within groups only. Cultures for each experimental
group were set up on separate days owing to the amount of work and
length of time required for each culture.
3.3 Suppression of Serum Antibody Responses by Feeding Ovalbumin
The anti-OVA response of mice 3 weeks after an immunization with
100 pg OVA in FCA injected into the footpad is shown in figure 2. The
mean haemagglutinating antibody titre of mice fed 25 mg OVA 7 days
before OVA immunization (Group 2) is significantly suppressed compared
to mice which were fed saline and then immunized (Group 1 versus Group
2, P ( 0.01).
GROUP DAY -2 DAY 0 DAY 7 DAY 27 DAYS 28 - 29
1 Fed OVA Bleed DTH Test
Saline Immunized or LTT
2 _ Fed OVA Bleed DTH
OVA Immunized or LTT
3 CY i.p. Fed OVA Bleed DTH
OVA Immunized or LTT
FIGURE 1
Experimental protocol to test the induction of tolerance to
ovalbumin by feeding and the effect of cyclophosphamide pre-
treatment.
CY was injected at 100 mg/kg dose.
Mice were fed either 25 mg OVA dissolved in 0.2 ml Sal or 0.2 ml Sal
only.
Mice were immunized with 100 yug OVA in CFA.
DTH was elicited in a footpad by injection of 100 yug OVA dissolved
in 0.05 ml saline.
3.4 Suppression of Delayed Hypersensitivity by Feeding Ovalbumin
Shown also in figure 2, a single feed of 25 mg OVA induces
suppression of the DTH response to a subsequent immunization with OVA
in FCA compared to the normal response of mice fed saline prior to
immunization (Group 1 versus Group 2, P 0.05).
3.5 The Effect of Cyclophosphamide on Systemic Immunity after OVA
Feeding
A dose of 100 mg/kg CY injected i.p. 2 days before OVA feeding
abrogated the suppression of DTH induced by OVA feeding and a normal
DTH response was seen in this group (figure 2, group 3). However, in
the same mice given CY pretreatment, the serum antibody response
remained suppressed. This observation contrasts with the effect of CY
in BALB/c mice. Under identical experimental conditions, CY abrogates
tolerance of both antibody and DTH responses in BALB/c mice (Mowat et_
al, 1982). This abrogation of only DTH tolerance by CY in BDFI mice
has been confirmed independently by Strobel and by Hanson (personal
communications, 1982).
3.6 Proliferative Responses of Lymph Node Cells in vitro: Effects of
OVA Feeding and CY Pretreatment
The results obtained by lymphocyte transformation assays are
given in Table 1. The group numbers correspond to those of*the
experimental protocol in figure 1. That is, Group 1 were immunized
with 100 yg OVA in FCA. This treatment previously induced a positive
DTH result in vivo (figure 2) and the in vitro LTT shows the presence




































Systemic Humoral and Cell-Mediated Responses of BDFI Mice Fed
Either Saline or OVA One Week Before Immunization and the Effect
of Cyclophosphamide Prior to OVA Feeding.
Experimental groups as referred to in Figure 1: 1; saline fed,
2; OVA fed, 3; CY treated, OVA fed.
Antibody was measured by indirect haemagglutination.
DTH was measured as footpad swelling 24 hrs after antigen challen
Responses were assayed 21 days after OVA immunization.
of identically treated mice (P ^ 0.001, OVA-containing compared to
unstimulated wells). No stimulation was seen in cells from mesenteric
lymph nodes.
Group 2 shows the in vitro response of cells from mice fed OVA
and then OVA-immunized. This treatment caused suppression of DTH in
vivo (figure 2), however, primed cells are still present in the
draining lymph nodes of these animals and respond to OVA in vitro
(cells with OVA versus unstimulated wells, P\ 0.001). Mesenteric
lymph nodes did not respond to OVA in this test.
Group 3 is the response of CY-treated OVA-fed mice which show a
positive result in a DTH skintest due to the abrogation of oral
tolerance. The stimulation index of peripheral lymph node cells with
OVA shows OVA-driven transformation and indeed the mean cpm is
significantly higher than unstimulated cells (P { 0.001). However,
the counts obtained are low overall compared to groups 1 and 2 and
illustrate the variability of this test. The mesenteric lymph node
cells responded to OVA sufficiently to cause a significant increase in
mean cpm (P ^ 0.005, stimulation index = 2.6) but this in turn was
still significantly lower than the response of peripheral node cells
(P ( 0.001).
3.7 Conclusions and Discussion of Section (a)
Lymphocyte transformation in response to OVA in vitro correlates
with the presence of a DTH response in mice immunized with OVA in
adjuvant and has been previously reported by Miller and Hanson, 1979.
This also extends the observations of Mowat (Mowat and Ferguson, 1981)
that inhibition of migration of lymphocytes in vitro in the presence
















1 PLN + PHA 1292 + 113 (33) < 0.001 -
PLN + OVA 2869 + 855
(84.4) < 0.005 < 0.005
PLN 34+27 (1) - -
MLN + PHA 1747 + 564
(103) <4 0.005 —
MLN + OVA 25+8 (1.5) N. S. -
MLN 17+2 (1) - -
2 PLN + PHA 514 + 167
(12.5) < 0.0C5
PLN + OVA 1261 + 177
(30.8) 0.001 < 0.001
PLN 41 + 27 (1) - -
MLN + PHA 1041 + 259
(43.4) </ 0.001 _
MLN + OVA 20 + 11
(0.3) N. S. _
MLN 24 + 13 (1) - -
3 PLN + ?HA 790 + 1S8
(21.4) <0.001
PLN + OVA 634 + 104
(17.1) < 0.001 < 0.001
PLN 37+3 (1) - -
MLN + PHA 204 + i65
(29.1) N. S. _
MLN + OVA 18 + 2 (2.6) ( 0.005 -
MLN 7+3 (1) - -
TABLE 1
4
Proliferative Responses of OVA-Immunized Mice: Effects of OVA Feeding
and CY Pretreatment.
Experimental groups as referred to in Figure 1: 1; saline fed, 2;
OVA fed, 3; CY treated, OVA fed.
Cells were collected from BDFI mice 21 days after immunization with OVA
Suppression of the in vitro proliferative response of PLN cells
after antigen feeding and immunization has been previously reported by
other workers (Miller and Hanson, 1979; Silverman et al, 1983). In my
experiments using assays of this kind, I was unable to detect
suppression of the proliferative response in mice with suppressed DTH
responses, for example those mice which were fed OVA prior to
immunization. I tested lymphocyte transformation at 21 days after
immunization. This was in contrast to Miller and Hanson who tested at
8 days after immunization and Silverman et al who used a similar
protocol for BSA. However, the in vitro inhibition of migration of
lymphocytes taken from the draining lymph nodes of mice immunized with
OVA in FCA injected into the footpad, developed in this laboratory by
Dr Allan Mowat, revealed no OVA-specific inhibition of migration
before 3 weeks following OVA immunization and this was influential in
my decision to test for activated cells from the same source at this
time. Mowat observed that production of a lymphocyte migration
inhibition factor did not always correlate with the presence of DTH,
(Mowat and Ferguson, 1981). It is not too surprising therefore, that
different regimes of immunization and sampling may highlight different
phases of the highly regulated response to a fed protein antigen.
I used slightly different culture conditions from the 2 groups of
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workers mentioned above, labelling cells with C instead of tritium
for example, and using a different number of cells per well cultured
in supplemented RPMI 1640. These conditions were based on4 my
preliminary experiments determining the optimum conditions for a
proliferative response using cells from the draining lymph nodes of
mice immunized with OVA in FCA.
The response of CY-treated, OVA-fed and immunized mice (Table 1,
group 3) is difficult to interpret. Peripheral nodes produce a
positive response to OVA although the degree of this response relative
to DTH is impossible to tell from this experiment. The mesenteric
lymph nodes also exhibit low grade transformation although this was
much less than the peripheral lymph node cells. It seemed feasible
that the systemic injection of antigen in Freund's complete adjuvant
produced an exaggerated peripheral response compared to that in the
mesenteric lymph nodes which were not adjuvant stimulated. I
therefore decided to study the in vitro responses of lymphocytes from
mice which were fed antigen and not systemically immunized. These
experiments are described in section (b) of this chapter.
SECTION (b): LOCAL CMI REACTIONS OF PERIPHERAL AND MESENTERIC LYMPH
NODE CELLS FOLLOWING OVALBUMIN FEEDING: EFFECTS OF CYCLOPHOSPHAMIDE
PRETREATMENT
3.8 Lymphocyte Transformation One Week After OVA Feeding and the
Effect of Cyclophosphamide
Previous work by Dr Mowat in this laboratory had shown that cells
from the mesenteric lymph nodes of mice injected with 100 mg/kg CY 2
days prior to OVA feeding showed in vitro inhibition of lymphocyte
migration in the presence of OVA. This response developed within 24
hours of a single OVA feed and persisted for 14 days. Mice fed OVA
without previous CY injection did not exhibit this response (Mowat'and
Ferguson, 1981).
I studied local immunity based on the cyclophosphamide model
using LTT instead of migration inhibition and comparing the responses
of mesenteric and peripheral lymph nodes within the same animals to
determine whether a true local immunity developed, for example, in the
mesenteric lymph nodes without concomitant peripheral activation.
A single time point was selected for initiation of the LTT at 7
days after feeding 25 mg OVA. This single feed on day 0 was
previously sufficient to induce oral tolerance (section 3.2). Seven
days after feeding was the usual interval before systemic challenge to
measure in vivo suppression and also came midway in the time after
feeding when specific migration inhibition of lymphocytes could be
detected in CY-treated mice. Lymphocyte transformation was assessed
in mice given 100 mg/kg CY at 9 days before culture and also in
mice given either a single feed of 25 mg OVA 7 days before culture.
The experimental protocol is summarised in figure 3.
In these experiments, where mice were not systemically immunized
with antigen in adjuvant, the peripheral lymph nodes were small and so
in order to have enough cells for culture, both popliteal nodes and
both inguinal lymph nodes were taken. As before, each experimental
group was set up as a separate culture.
The antigen dose-response to OVA had been determined using
peripheral lymph nodes. As a precaution that the optimum OVA dose for
transformation of mesenteric lymph node cells might vary slightly,
group 4 was set up for 3 different doses of OVA around the optimum
dose for peripheral stimulation. That is, 200 p.g, 250 jig and 300
jdg per well.
The results of this experiment are summarised in table 2. Gfoup
6 which had been injected with CY only showed no in vitro response to
OVA after 9 days either in peripheral or mesenteric lymph nodes. The
background count in unstimulated wells was observably higher in cells
from CY-treated mice than in those which were not given CY (group 5).
GROUP DAY -2 DAY 0 DAY 7
4 CY i.p. Fed OVA LTT
5 - Fed OVA LTT
6 CY i.p. - LTT '
FIGURE 3
Experimental protocol to test lymphocyte transformation 7 days
after feeding and the effect of cyclophosphamide pretreatment.
CY was injected at a dose of 100 mg/kg.OVA was fed at a dose of









4 PLN + PHA 1194 4- 333 (2.3) < 0.025
PLN + OVA 96 -r 14 (0.2) < 0.005
PLN 424 +» 126 (1) -





(300 yg) 653 275 (4.3) <0.02
MLN + OVA
(250 yg) 986 +• 589 (7.2) N. S.
MLN + OVA
(200 jig) 1147 224 (8.4) <" 0.001
MLN 137 -r 29 (1) -




PLN + OVA 7 + 2 (17.5) < 0.05
PLN4 0.4 * 3.5 (1) -
MLN + PHA 1305 + 63 (.52.1 ) < 0.001
MLN + OVA 55 -4- 17 (2.6) < 0.05
MLN 21 +■ 13 (1) -
5 PLN + PHA 1354 -f 231 (6.6) O oo!
PLN + OVA 249 -t- 77 (1.2) N. S.
PLN 205 S6 (1) -
MLN 4- PHA 1475 263 (6.8) <( 0.001






Proliferative Responses of Non-Immunized Mice: Effects of OVA Ceding
+ CY Pretreatment.
Experimental groups as referred to in Figure 3: 4; CY treated, OVA
fed, 5; OVA fed, 6; CY treated only.
Mice were injected with CY 2 days prior to OVA feeding.
Cells were obtained from 3DFI mice 7 days after OVA feeding or 9
days after CY treatment (2 days + 7 days)
The mesenteric lymph node response of OVA-fed mice (group 5) was
sufficient to cause a significant increase in cpm (P \ 0.05 compared
to unstimulated wells) although the stimulation index only reached
2.6. The background response of peripheral lymph node cells in group
5 was unusually low (0.4 + 3.5). This produced artificially high
stimulation indices and a significant difference in mean cpm of
OVA-stimulated wells. This is pseudo-stimulation and is not the
result of transformation in the test wells since the mean cpm obtained
with OVA was only 1 + 2.
Group 4 which were CY-treated and OVA fed also showed higher
background counts than group 5 which had not been CY-injected.
Mesenteric node cells with 300 fig and 200 fig OVA added had a
significant increase in mean cpm compared to unstimulated wells. The
250 fig OVA dose caused an increase in mean cpm which was not
significant due to the large standard error of the mean which was the
result of well-well variation. Nonetheless the optimum OVA dose for
mesenteric lymph node cells seems to be the same as for peripheral
cells.
Cells from peripheral nodes in group 4 did not respond to OVA and
the counts obtained were even lower than background on this occasion.
Because of the apparent stimulation in mesenteric lymph node
cells following CY injection and OVA feeding, this culture group
(group 4) was repeated twice further. The results of these repeat
test are given in table 3. 4
In both subsequent tests, no OVA-specific stimulation of
mesenteric lymph node cells was found. The stock antigen solution
used in all three cultures was tested by the Microbiology Department
in the Western General Hospital and found free of contamination by
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Culture mean cpm + s.e. P value, compared
Group Containing (stimulation index) to unstimulated
4 PLN + PHA 991 + 435 (8.6) /V O O IV)
(2nd PLN + OVA 357 + 116 (3.1) N. S.
test)
PLN 115 + 12 (1) -
MLN + PHA 956 + 281 (10.8) <; 0.005
MLN + OVA 95+47 (1.1) N. S.
MLN 88+11 (1) -
4 PLN + PHA 1603 + 831 (69.6) <.0.02
(3rd PLN + OVA 51+8 (2.2) <0.02
test)
PLN 23+12 (1) -
MLN + PHA 1551 + 235 (24.6) < 0.001
MLN + OVA 80+23 (1.3) N. S.
MLN 63+4 (1) _
TABLE 3
Proliferative Responses of Non-Immunized Mice: Repeated Tests in CY
Treated OVA Fed Mice
4
Experimental groups as referred to in Figure 3.
Cells were obtained from BDFI mice 7 days after OVA feeding. Mice
were injected with CY 2 days prior to OVA feeding.
bacteria thus ruling out the possibility of false counts being
obtained in the first test due to either proliferating bacteria or
lymphocyte stimulation in response to bacterial products.
I decided to run a time-course of cultures from CY-treated
OVA-fed mice commencing 1 day after feeding and continuing daily for 6
days. I reasoned that the low grade mesenteric lymph node response
seen in the first test at 7 days after feeding, may have been residual
activity indicative of a response occurring earlier and so might not
always be above the limits of detection of my assay at 7 days. I also
followed the in vitro response of peripheral lymph node cells at
different times after OVA feeding only, and compared the responses
where possible with those of mesenteric lymph nodes from the same
animals.
3.9 Time-Course of Lymphocyte Transformation in CY-Treated OVA-Fed
Mice
BDFI mice were injected i.p. with 100 mg/kg CY and fed 25 mg OVA
2 days later. Groups of 5 to 6 mice were then killed daily for up to
6 days after feeding and had mesenteric and peripheral lymph node
cells cultured. The results of these cultures are combined in Table
4.
. Cells taken from peripheral lymph nodes at 1 day after OVA
feeding showed a significant increase in cpm when cultured with OVA
compared to control wells (P ^ 0.025) and had a stimulation indeft of
3.7. Mesenteric lymph node cells had a stimulation index of 4 in the
presence of OVA but did not show a significant increase in mean cpm (P/
0.2). No antigen-specific activity was seen in cultures initiated at
2, 3 and 4 days after OVA-feeding with CY pretreatment.
Days after
OVA Culture Mean cpm + s.e. P value, compared
Feeding Containing (stimulation index) to unstimulated
1 PLN + PHA 712 + 154 (28.5) < 0.001
PLN + OVA 93 + 38 (3.7) C 0.025
PLN 25 + 10 (1) -
MLN + PHA 726 + 228 (66) < 0.005
MLN + OVA 44 + 31 (4) N. S.
MLN 11+4 (1) —
2 PLN + PHA 554 + 184 (19.7) < 0.005
PLN + OVA 32 + 14 (1.1) N. S.
PLN 28 + 17 (1) -
MLN + PHA 1054 + 59 (45.8) < 0.001
MLN + OVA 29 + 5 (1.3) N. S.
MLN 23+14 (1) —
3 PLN + PHA 776 + 283 (17.6) <0.02
PLN + OVA 33 + 13 (0.75) N. S.
PLN 44+9 (1) -
MLN + PHA 318 + 56 (4) < 0.001
MLN + OVA 27 + 14 (0.34) < 0.01
MLN 79+16 (1) —
4 PLN + PHA 1309 + 533 (32.7)• <0.02
PLN + OVA 55 + 9 (1.4) N. S.
PLN 40 + 4 (1) -
MLN + PHA 2294 + 422 (11.9) <0.001
MLN + OVA 250 + 112 (1.3) N. S.
MLN 193 + 19 (1) —
5 PLN + PHA 3717 + 520 (56.3)
b
<• 0.001
PLN + OVA 349 + 190 (5.3) < 0.05
PLN 66 + 41 (1) -
MLN + PHA 1192 + 637 (3.5) N. S.
MLN + OVA 870 + 273 (2.5) < 0.025
MLN 338 + 64 (1) —
6 PLN + PHA 1769 + 1130 (12.8) N. S.
PLN + OVA 265 + 67 (1.9) N. S.
PLN 138 + 82 (1) -
MLN + PHA 2808 + 211 (14.9) <0.001 *
MLN + OVA 1406 + 548 (7.5) <0.02
MLN 188 + 52 (1) —
TABLE 4
Proliferative Responses of Non-Immunized Mice: Time-course of Response
Following CY Treatment and OVA Feeding.
BDFI mice were injected with CY 2 days prior to OVA feeding.
Cells were obtained at various times following OVA feeding.
On the 5th day after OVA feeding, both peripheral and mesenteric
lymph node cells showed a significant increase in cpm in response to
OVA (PLN P ^ 0.05; MLN, P ^ 0.025) with stimulation indices of 5.3 and
2.6 respectively. Six days after feeding the response in mesenteric
lymph node cells had continued to rise and the stimulation index was
now 7.5 with mean cpm significantly greater than control wells without
OVA (P ^ 0.02). This result is similar in degree to the one previous
culture of mesenteric lymph nodes (Group 4, table 2) at 7 days after
OVA-feeding in CY-treated mice which showed OVA-driven transformation.
The peripheral lymph node culture 6 days after feeding produced a
disappointing result with large variation between wells such that no
significant difference was found in either PHA or OVA-stimulated
cultures.
3.10 Lymphocyte Transformation Following OVA Feeding
Mice were fed 25 mg OVA on day 0 and on days 1, 3, 5, 7 and 14,
groups of mice were used as a source of cells for cultures. The
results of these cultures are summarised in table 5. Cells from
peripheral and mesenteric lymph nodes collected 1 day after OVA
feeding showed in vitro responsiveness to OVA, having a significantly
increased mean cpm compared to unstimulated cells (PLN, P/ 0.05; MLN,
P ^ 0.05), however, the response was quite low-grade with stimulation
indices of 1.9 and 2.6 in peripheral and mesenteric nodes
respectively. A similar low-grade response was found" in peripheral
lymph nodes only, at 3 days after feeding and this was absent it 5
days.
More than one test was run at 7 days after feeding and the first
test revealed no response in mesenteric lymphocytes. This is unlike
the 7 day control group which were fed OVA only in the experiment
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Days after Culture Mean cpm + s.e. P value, compared
OVA feed containing (stimulation index) to unstimulated
1 PLN + PHA 674 + 317 (25.9) 0.02
PLN + OVA 49 + 9 (1.9) 0.05
PLN 26 + 8 (1) -
MLN + PHA 981 + 208 (37.7) 0.001
MLN + OVA 67 + 21 (2.6) 0.05
MLN 26+11 (1) —
3 PLN + PHA .510 + 57 (31.8) 0.001
PLN + OVA 32+9 (2) 0.005
PLN 16 + 5 (1) -
MLN + PHA 1110 + 132 (30) 0.001
MLN + OVA 42 + 6 (1.1) N. S.
MLN 37+10 (1) —
5 PLN + PHA 829 + 216 (27.6) 0.001
PLN + OVA 44 + 14 (1.5) N. S.
PLN 30+11 (1) -
MLN Not determined
7 PLN + PHA 270 + 113 (2.7) = 0.05
(1st test) PLN + OVA 108 + 26 (1.1) N. S.
PLN 100 + 57 (1) -
MLN + PHA • 821 + 86 (25.6) 0.001
MLN + OVA 30+4 (0.9) N. S.
MLN 32+10 (1) —
7 PLN + PHA 1055 + 367 (34) 0.01
(2nd test) PLN + OVA 197 + 84 (6.4) 0.02
PLN 31+10 (1) -
MLN Not determined
14 PLN + PHA 1473 + 387 (25.8) 0.001
PLN + OVA 262 + 95 (4.6) m*—IOO
PLN 57+9 (1) -
MLN Not determined
TABLE 5
Proliferative Responses of Non-Immunized Mice Following OVA Feeding.
Cells were obtained from BDFI mice at various times following OVA feeding.
including CY-treated mice (Group 5, table 2). In this case, OVA-fed
mice showed an in vitro response to OVA in mesenteric lymph nodes.
The peripheral lymphocyte culture at 7 days after OVA feeding was
not successful, having low counts in the PHA wells, however, a second
test of peripheral lymphocytes revealed stimulated cells (P^ 0.02
compared to controls) with a stimulation index of 6.4. Similarly at
14 days after feeding a noticeable response occurred in peripheral
lymphocytes with a stimulation index of 4.6 obtained and 0.01 when
the mean cpm was compared to control wells.
*
3.11 Conclusions and Discussion of Section (b)
Activated T cells can be detected in the mesenteric lymph nodes
of CY-treated mice between 6 and 7 days following OVA-feeding and may
be an indication of mucosal CMI. However, the response measured by
lymphocyte transformation is slight and difficult to reproduce.
Peripheral lymph node cells from normal mice fed OVA also showed
some in vitro stimulation in the presence of OVA at 1, 3, 7 and 14
days after antigen feeding. The response at 1 day after OVA feeding
was also seen in mesenteric lymph nodes and may illustrate the
initiation of responsiveness in the animal. A similar early increase
in the proliferative response of mesenteric lymph node cells was
previously observed by Silverman et al in mice fed BSA. This response
dropped below background level after 2 days and, unlike my results,
was not seen in peripheral lymph nodes. (Silverman et al, 1983). *
No functional studies were carried out on the responding
peripheral lymph node cell population other than determining that the
in vitro transformation in response to OVA was T cell dependent. With
this in mind it is still interesting to note that the spleens of BDFI
mice fed sheep enthrocytes have been found to contain DTH effector
cells (Kagnoff, 1978 b) and, in a separate study, helper T cells for
plaque-forming cell responses (MacDonald, 1982). Systemic T cell
priming by antigen feeding is no new phenomenon therefore.
The in vitro response of cells from those mice fed antigen and
not stimulated with OVA in FCA were extremely low. I was unprepared
for this as the assay had been developed using cells from lymph nodes
draining footpads injected with OVA in FCA. Under these latter
conditions only a small amount of C ^-thymidine (0.01 yCi) was
required per well in order to detect transformation. The same amount
of label used in the later tests may have severely limited detection
of the lower responses of mice given OVA orally and even pushed the
assay to the limits of its sensitivity. This might account for some
of the results which were non-reproducible. The lymphocyte
transformations were also prone to variation and this too made data
difficult to interpret.
These experiments were being carried out in parallel with another
series of experiments designed to investigate in vivo the regulation
of systemic responses to orally administered protein antigen by
studying the nature of the regulatory stimulus produced as a
consequence of antigen feeding. This latter line of research was proving
more fruitful than my in vitro studies and eventually when a choice had to
be made regarding the final direction of my research within a limited
period of time, I chose to follow up the in vivo experiments. Thesl





As discussed in the general introduction to this thesis, the
intestine has the potential for immunoregulation via physico-chemical
modification of ingested antigen: antigen processing. The importance
of antigen processing by the gut in the induction of oral tolerance
was examined by studying the in vivo immunological effect of antigen
which had been absorbed across the gut into the serum.
In collaboration with Dr Allan Mowat and Dr Stephan Strobel, a
serum transfer protocol was devised. Serum was collected from mice 1
hour after feeding a tolerizing dose of OVA and transferred into
syngeneic recipients. The immunological properties of OVA in the
transferred serum were then assessed by immunizing the serum
recipients with OVA in adjuvant and measuring their subsequent humoral
and cell-mediated immunity. A similar protocol was also used to
determine the mechanism by which oral tolerance is abrogated by CY.
Cyclophosphamide is known to inactivate suppressor cells (Gill and
Liew, 1978; Sy et al, 1977; Atallah _et al_, 1979), but by virtue of
its alkylating action on dividing populations of cells such as
enterocytes (Ecknauer and Lohrs, 1976; Sobhon _et _al, 1977), CY may
also affect the intestinal processing of OVA such that the antigen
does not provide the appropriate immunological stimulus to the host.
These hypotheses were tested by injecting serum donors with CY 2 days
prior to transfer of their sera and by injecting recipients with CY 2
days prior to serum injection. If gut-processing is affected by*CY,
then pretreatment of donors might alter the consequent immunological
effects of transferred serum. However, if CY abrogates oral tolerance
by inactivating suppressor cells then serum recipients given CY should
have altered responses to the gut-processed antigen.
4.2 Experimental Design
BALB/c mice were treated according to the following experimental
protocol. Groups of 20 donor mice were fed 0.2 ml water (Group A) or
else 25 mg OVA in 0.2 ml water (Group B) by intragastric intubation
and were bled out from the axillary vein and artery one hour later.
The sera collected in each group were pooled and 0.8 ml injected into
each of 6 recipients i.p.. Two groups of donors were injected i.p.
with 100 mg/kg CY 2 days before feeding water or OVA (Groups C and D)
and similarly, two groups of recipients were given CY 2 days prior to
injection of serum (Groups E and F). One week after serum transfer,
all recipients were immunised by an injection of 100 yg OVA in FCA
into the right hind footpad. Recipients were bled from the
retro-orbital plexus at 2 and 3 weeks after immunization and their
sera assayed for anti-OVA antibodies by haemagglutination. At 3 weeks
after immunization the mice were also skintested for DTH by injecting
100 yg OVA in saline into the left footpad and measuring the 24 hour
increment in footpad thickness. The basic design of this type of
experiment is illustrated in figure 4.
4.3 Systemic Response of Serum Recipients
Recipients of serum from water-fed or OVA-fed donors had
identical levels of IgM at 2 weeks and IgG at 3 weeks after
immunization (figure 5). In contrast (figure 5), recipients of serum
from OVA-fed mice had suppressed DTH responses compared to recipients
of serum from mice which were fed water (P^0.02).
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FIGURE 4
Basic design of Serum Transfer Experiments.
Mice were fed 25 mg OVA dissolved in 0.2 ml saline (or H^O) or 0.2 ml
saline (or H^O) only.
Antibody was measured either by indirect 'naemagglutination or by ELISA.
DTH was elicited in the footpad by an injection of 100 ug OVA in
saline (0.05 ml). The response was measured as the mean increment*
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FIGURE 5
Systemic cell-mediated and humoral response of recipients of serum from
H^O fed or OVA fed donors.
Group A; received serum from H^O fed donors collected 1 hr after feeding
Group B; received serum from OVA fed donors collected 1 hr after feeding
Shading represents mercaptoethanoi-sensitive Ab
Antibody was measured by indirect haemagglutination. DTH was measur§d as
footpad swelling 24 hrs after antigen challenge.
Responses were assayed 21 days after OVA immunization.
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4.4 Effect of CY Pretreatment of Serum Donors and Recipients
This can be seen in figure 6. Pretreatment of serum donors with
CY 2 days before water or OVA feeding (Groups C and D) had no effect
on the humoral antibody responses of recipients nor did it affect the
suppression of DTH in recipients of serum from CY-treated, water-fed
donors (Group C versus Group D, 0.01).
Serum recipients pre-treated with CY (Groups E and F) showed
identical antibody responses to untreated recipients (Groups A and B).
However, the suppression of DTH in recipients of serum from OVA-fed
donors is abrogated by CY pretreatment of recipients (Groups E and F).
4.5 Antigen-Specificity of Serum-Transferable Tolerance.
The above experiments were performed in BALB/c mice. As I
intended using BDFI strain mice throughout my programme of research I
repeated the experiments in BDFI mice and included with these a test
to determine whether the immunological effects of transferred serum
were antigen-specific.
Serum from BDFI mice was collected one hour after feeding OVA or
saline as before and transferred into recipients which were
subsequently immunized with either 100 yg OVA in FCA or 100 pg human
serum albumin (HSA) in FCA. HSA does not cross-react with OVA and was
not present in the laboratory mouse diets. Antibody level% in
recipients were measured by an ELISA which detected anti-OVA IgG.
This test was developed as a means of measuring serum antibody
directly as opposed to the indirect haemagglutination assay.
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FIGURE 6 'UUR!
Systemic Humoral and Cell-Mediated Responses of Recipients of Serum from
H^O Fed or OVA Fed Donors: Effects of Cyclophosphamide Treatment of
Donors and Recipients.
Antibody was measured by indirect haemagglutination. DTH was measured as
footpad swelling 24 hrs after antigen challenge.
Responses were assayed 21 days after OVA immunization.
Groups A, C, E received serum from H^O fed donors
Groups B, D, F, received serum from OVA fed donors
Groups C, D; serum donors treated with CY
Groups E, F; serum recipients treated with CY
Shading represents mercaptoethanol-sensitive Ab
donors 3 weeks after an immunization with OVA or HSA in FCA is shown
in figure 7. As seen in BALB/c mice (figure 5) the DTH response to
OVA is suppressed by transfer of serum from OVA-fed mice (p ^ 0.005)
and not affected by serum from saline-fed mice. The transfer of
suppression with serum from OVA-fed mice was therefore confirmed for
BDFI mice also. The DTH response to HSA is not suppressed by serum
transfer from saline or OVA-fed mice (p = 0.4).
Figure 8 confirms that the 2 antigens, OVA and HSA are
antigenically distinct. The anti-OVA response of serum recipients,
expressed as ELISA readings of optical density at 405 nm, is absent in
mice immunized with HSA (P^ 0.01). Similarly the anti-HSA response
of OVA-immunized mice is negative. The lower response of HSA
immunized compared with OVA immunized mice indicates that at this
dose, HSA does not elicit as high a response as OVA.
These results also demonstrate that the humoral responses of BDFI
recipients of serum from OVA-fed syngeneic donors are not suppressed.
4.6 Conclusions
The transfer of tolerance to OVA with serum from OVA-fed BALB/c
mice indicates that tolerance of CMI after feeding OVA is induced in
these mice by circulating antigen absorbed from the gut. My
experiments also confirmed this phenomenon in another strain of mice,
BDFI, which shows that the effect is not merely a peculiarity of
BALB/c mice. Incorporated into the experiments in BDFI mice wfes a
test of the antigen-specifity of tolerance induced by an injection of
serum from OVA-fed mice. Tolerance was OVA-specific. This shows that
the induction of tolerance for CMI by serum transfer was a true























Cell-mediated response of recipients of serum from Saline Fed or
or OVA Fed donors.
Shaded areas represent those groups of mice injected with serum from
OVA fed mice.
Unshaded areas represent groups of mice injected with serum from sal
fed donors.
Serum was collected 1 hr after feeding
DTH was measured as footpad swelling 24 hrs after antigen challenge
The response was assayed 21 days after immunization.
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immunization
Humoral responses of recipients of serum from Saline fed or OVA fed
donors.
Shaded areas represent those groups of mice injected with serum from
OVA fed mice.
Unshaded areas represent groups of mice injected with serum from sal
fed donors.
Serum was collected 1 hr after feeding.
Antibody (IgG) was measured by ELISA (OD 405 nm).
The response was assayed 21 days after immunization.
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tolerance for CMI with normal humoral immunity in serum recipients
shows that these two limbs of immunity differ in their susceptibility
to tolerance induction and may be regulated by separate mechanisms.
Cyclophosphamide injected at a dose of 100 mg/kg does not alter
the normal uptake and processing of OVA by the gut since CY-treated
serum donors were as efficient as non-treated at processing OVA to
induce tolerance in recipients.
The altered response of CY-treated recipients to the tolerogenic
stimulus offered by serum from OVA-fed mice indicates the presence of










The results of experiments described in Chapter 4, that OVA
feeding produced a tolerogen in serum, dictated further research: The
suppression of DTH by a serum-borne tolerogen may have been the result
of effectively introducing a low dose of OVA into the circulation by
feeding, or, the antigen may have been altered to tolerogenic form
either by the gut, or by systemic antigen processing once the antigen
had reached the circulation.
Estimates of the amount of OVA in serum 1 hour after a single
feed of 25 mg OVA have been obtained by co-workers using inhibition of
haemagglutination (Mowat, 1982) and ELISA (Strobel, 1983). In
agreement with other workers measuring antigen uptakes after feeding,
the amount of OVA in serum was found to be extremely variable with a
wide range of 0.01% - 1% of ingested dose being detected in the serum.
Therefore, in experiments to determine the effect of low doses of OVA
on subsequent immunity, mice were injected i.v. with 3 different doses
of OVA within this range, that is, 0.1 ^ig, 1 pg and 10 jig, and were
subsequently immunized and challenged.
Alteration in antigen form by intestinal processing was another
possible explanation for serum-transferrable tolerance after
OVA feeding and so, additional groups of animals were injected with
urea-denatured and alkylated OVA (denatured OVA) and also deaggregated
ovalbumin over the same range of doses as native OVA and were likewise
immunized and challenged with native OVA. Deaggregated proteins are
known to be tolerogenic (Lukic et al, 1975; Parks and Weigle, 1980 a)
and I wanted to test the tolerogenicity of deaggregated OVA in this
particular dose range to see whether deaggregated OVA behaved like
gut-processed OVA. Similarly if denaturation of proteins reveals
tolerogenic stimuli (Goetzl and Peters, 1972; Takatsu and Ishizaka,
1975), denatured OVA might also behave like a product of
gut-processing.
In addition to these i.v. injections of native, denatured and
deaggregated OVA, a parallel experiment was set up with these antigens
being injected via the intra-peritoneal route. This was done in order
to compare the 2 routes of antigen entry; one directly into the
circulation, the other via lymphatic drainage, to see whether these
effected different immunological signals to the host. Miller et al
(1979) had previously demonstrated a difference in response to
cell-bound protein antigen administered subcutaneously compared to
intravenous injection of the same antigen. In my experiments the
serum from mice fed OVA was normally injected i.p. and so it was
important to check the effect of route of antigen entry on
immunological outcome.
5.2 Experimental Design
Groups of 6 BDFI mice were injected with 0.1, 1 or 10 _pg of
either native OVA, denatured OVA or deaggregated OVA. In one
experiment the injections were given i.v. and in another, i.p.. Each
experiment included a group of control mice which were injected with
physiological saline either i.v. or i.p. as appropriate. One week
later, all mice were footpad-immunized with OVA in FCA and were bled
20 days later in order to assess their humoral antibody response by
ELISA. A DTH footpad skintest was carried out on day 21 after
immunization and read on day 22.
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5.3 Humoral and Cell-Mediated Immunity Following i.v. Injection of
OVA
Mice injected i.v. with native or denatured OVA prior to
immunization had identical antibody responses to mice injected with
saline before immunization. Deaggregated OVA on the other hand,
suppressed the anti-OVA response over the entire test range of antigen
doses (figure 9).
Similarly, the DTH responses of mice injected i.v. with saline,
native OVA or denatured OVA were not significantly different for all
three doses of OVA injected whereas deaggregated OVA induced
suppression of DTH to native OVA at every dose tested (figure 9).
5.4 Humoral and Cell-Mediated Immunity Following i.p. Injection of
OVA
The administration of OVA via the i.p. route produced the same
pattern of responsiveness as did i.v. injections (figure 10). That
is, deaggregated OVA suppressed both the humoral and cell-mediated
responses for each dose used in the experiment whilst native and
denatured OVA had no effect on the immune response. These mice
behaved like the saline-injected controls and were neither primed nor
tolerized by this low dose of antigen.
5.5 Determination of The Role of Systemic Processing of Antigen
To determine the role of the reticulo-endothelial system in
rendering OVA tolerogenic subsequent to its entry into the systemic











Humoral and cell-mediated responses of BDFI mice injected i.v. with
native, denatured or deaggregated OVA prior to immunization with native
OVA.
Mice were injected i.v. as follows:
Dotted areas; saline, unshaded areas; native OVA, shaded areas den OVA
hatched areas; deaggregated OVA.
Antibody (IgG) was measured by ELISA (OD 405 nm). DTH was measured by


































Humoral and cell-mediated responses of BDFI mice injected i.p. with
native, denatured or deaggregated OVA prior to immunization with native
OVA.
Mice were injected i.p. as follows:
Dotted areas; saline, unshaded areas; native OVA, shaded areas; den OVA,
hatched areas; deaggregated OVA.
Antibody (IgG) was measured by ELISA (OD 405 nm).
DTH was measured by footpad swelling 24 hrs after antigen challenge.
Responses were assayed 21 days after immunization.
technique had been used by other workers to investigate the importance
of antigen processing by macrophages in relation to immunogenicity,
(Frei et al, 1965; Lukic et al, 1975)
Mice were injected with antigen which was allowed to circulate
for 1 hour and thus be exposed to any systemic antigen processing
mechanism. After this time the mice were bled out and their serum
containing the "filtered" antigen injected into syngeneic recipients
which were then immunized and assessed for antibody and DTH responses.
The i.p. and i.v. routes of injection had produced no difference
in immune responses in the previous experiments and all antigen doses
tested had produced identical results. Native and denatured OVA had
both induced similar responses to native OVA. These antigens were now
tested for any difference in their systemic antigen processing.
Therefore, donor mice were injected i.p. with saline or.a selected
dose of 10 jag of either native or denatured OVA and were bled out one
hour after injection. The serum of these mice was injected into
recipients which were immunized with OVA as described above, bled for
serum antibody at 20 days and skintested for DTH on day 21 after
immunization.
The responses of serum recipients are shown in figure 11 and
reveal that after 1 hour in the systemic circulation, native OVA was
not rendered tolerogenic. Denatured OVA was also not altered in its
immunogenicity by this procedure and behaved like native OVA producing
positive antibody and DTH responses to native OVA which were slightly
higher than controls but not significantly different.
5.6 Conclusions
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FIGURE 11
Humoral and cell-mediated responses of recipients of serum from
donors injected i.p. with saline, native OVA or denatured OVA prior to
immunization.
Recipients were injected with serum collected from donors 1 hr after i.p.
injections as follows:
Dotted areas; saline, unshaded areas; OVA, shaded areas; den OVA.
Antibody (IgG) was measured by ELISA (OD 405 nm).
DTH was measured by footpad swelling 24 hrs after antigen challenge.
Responses were assayed 21 days after immunization.
route produced identical results: low doses of parenterally injected
native or urea-denatured ovalbumin given in a range of amounts
previously detected in serum 1 hour after a single feed of 25 mg OVA
did not induce tolerance to native OVA. This refutes the hypothesis
that tolerance transferred by serum collected 1 hour after an OVA feed
is due to the quantity of systemic antigen available.
Urea-denatured OVA did not differ from native in its effect on
the immune response and implies that this form of OVA is not a product
of gut-processing since the denatured protein was not tolerogenic.
Deaggregated OVA produced tolerance, at all doses employed, for both
DTH and serum antibody. Whether this reflects gut processing is not
clear since circulating gut-derived OVA did not induce tolerance for
antibody responses (chapter 4).
OVA which had been in the systemic circulation for 1 hour was not
tolerogenic. This excludes the possibility that OVA entering the
circulation via the gut is rendered tolerogenic after its absorption
and implies that the presence of tolerogenic OVA in serum after
feeding is due directly to antigen processing by the gut.
CHAPTER 6
ANTIGENIC CHARACTERISTICS
OF G U T - P R 0 C E S S E D OVALBUMIN
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6.1 Introduction
The results of chapters 4 and 5 previously have shown that OVA
which is absorbed into the circulation after feeding has been rendered
tolerogenic by gut processing and thus presents a suppressive signal
to the systemic immune system. Clearly, the characteristics of gut
processed antigen are of importance in the determination of a
mechanism for oral tolerance and also in the understanding of immune
recognition and regulation in general.
As discussed in the introduction to this thesis, different
functional classes of lymphocytes possess different antigen
recognition elements. B cells recognize certain antigenic
determinants by means of surface antibody and evidence exists that
suppressor T cells can recognize the same 3-dimensional conformational
structures as B cells (Endres and Grey, 1980 (a)).
If gut-processed OVA possesses determinants which B cells
recognize and therefore which might also be recognized by suppressor T
cells, OVA-specific antibody could be used to probe for them.
Further, if these determinants are required for the appropriate
tolerogenic stimulus to be presented to the immune system then their
removal should influence the immunogenicity of gut-processed OVA.
This hypothesis was tested by collecting serum from mice 1 hour
after feeding OVA and incubating the serum with anti-OVA antibody
coupled to Sepharose beads. Removal of the beads at the end of the
incubation was expected to remove gut-processed OVA bearing B cell
determinants. An ELISA technique was used to test serum from OVA-fed
mice before and after treatment with Sepharose for the presence of
immunoreactive OVA and the various binding phases of this ELISA are
described schematically in figure 12. The immunogenicity of absorbed
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FIGURE 12
Schematic diagram of ELISA for OVA detection
Plates are coated with rabbit IgG anti-OVA.
Serum is added (containing gut-processed OVA).
OVA in serum is detected with rabbit anti-OVA coupled to alkaline
phosphatase activated by p-nitrophenyl phosphate.
serum was then tested in vivo to determine the functional significance
of antibody-binding determinants in the induction of tolerance by
gut-processed OVA.
The nature of helper T cell recognition of gut-processed OVA was
not addressed by the experiments described above. This is a more
difficult problem to analyse since the means of T cell recognition of
antigen is largely unknown. However, in an attempt to investigate whether
gut-processed OVA possessed determinants which T cells recognise,
gut-processed OVA was added to cultures of lymphocytes from mice
immunized with OVA in Freund's complete adjuvant in order to test
whether OVA-primed helper T cells could be stimulated by the
serum-borne OVA to transform in vitro.
6.2 Use of Antibody-Coupled Sepharose as an Immunoadsorbent
Hyperimmune rabbit anti-OVA anti-serum was used as a source of
OVA-specific antibodies. Antibody was coupled to beads of Sepharose
4B, referred to as S4B-anti-0VA, and (Chapter 2, Section c) 200 jil of
S4B-anti-0VA could bind 5 pg OVA. A minimum estimate of 200 ng OVA
per ml of serum taken 1 hour after feeding 25 mg OVA was adopted based
on the results of Dr Strobel (personal communication 1983), and so 200
pi of S4B-anti-0VA added per 5 ml of serum would theoretically contain
more than enough antibody to remove an estimated 1 pg of OVA.
6.3 Treatment of Serum to Remove Gut-Processed OVA Bearing B Cell
Determinants
Groups of mice were fed either 0.2 ml saline i.g. or 25 mg OVA
and were bled out 1 hour later. A portion of each serum pool was
incubated with S4B-anti-0VA overnight at room temperature on a
revolving table. One aliquot of serum from OVA-fed mice was incubated
twice using fresh S4B-anti-0VA for the second incubation. This was
done to ensure the removal of all B cell-recognisable OVA from the
serum. Serum from saline-fed mice was also subjected to a double
incubation with S4B-anti-0VA. At the end of the incubation period,
the Sepharose was allowed to settle and the supernatant sera were
pipetted off. From each group, sufficient serum was kept aside and
tested in an ELISA for its concentration of OVA. The values obtained
were then compared with known OVA concentrations on a standard curve.
6.4 Ovalbumin Concentration in Serum Before and After Incubation With
S4B-Anti-0VA
Table 6 lists the amount of OVA detected by ELISA in aliquots of
pooled sera from 15 mice. The standard curve for this assay is given
in figure 13 and shows a linear relationship between optical density
at 405 nm (OD 405 nm) and l°g-|_o concentration for values betweeen
1 ,ug and 31.6 ng per ml (r = 0.99). Readings of less than 31.6 ng per
ml are therefore beyond the limits of accurate detection of the assay.
Serum from OVA-fed mice produced an ELISA reading within the linear
range giving a concentration of 38.0 ng per ml.
Serum from saline-fed mice which had been absorbed twice with
S4B-anti-0VA had an approximate reading of 7.59 ng/ml and since this
serum contained no OVA, all readings of 7.59 ng/ml or less are
considered as "background". therefore, the sera from saline-fed mice
and from OVA-fed mice after either 1 or 2 incubations with
S4B-anti-0VA can be said to contain no immunoreactive OVA.
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FIGURE 13
Standard curve of ELISA for OVA concentration.
The reading for serum from OVA fed mice is indicated by broken lines.













n = 15) 5.01 38.0 6.3 5.01 7.59
Lower limit of assay at 31.6 ng
TABLE 6
OVA (By ELISA) in serum of BDFI mice after saline or OVA feeding +
incubation with S4B-Anti-0VA
Serum was collected from BDFI mice 1 hr after Sal or OVA feeding and
treated with S4B-anti-0VA. "abs" refers to the number of incubations
with S4B-anti-0VA.
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6.5 Immunogenicity in vivo of Serum Absorbed with S4B-Anti-0VA
Groups of recipient mice were injected i.p. with 0.8 ml of the
serum from saline or OVA-fed mice which was prepared in section 6.3
above, and assayed for OVA concentration in section 6.4. One week
after serum injection, the mice were immunized with OVA in FCA as
usual and were bled and DTH skintested on days 20 and 21 respectively.
The systemic humoral and cell-mediated responses of these mice are
shown in figure 14.
Serum from OVA-fed mice suppressed the DTH response of recipients
compared to recipients of serum from saline-fed mice which had
strongly positive DTH (P ^ 0.05). Serum from OVA-fed mice which was
absorbed either once or twice with S4B-anti-0VA did not suppress the
DTH response to OVA when compared either with the response of
recipients of serum from saline-fed mice, or with that of recipients
of twice-absorbed serum from saline-fed mice.
The humoral antibody response of recipients of serum from OVA-fed
mice was significantly lower than the controls which were injected
with serum from saline-fed mice (P ^ 0.05). However, there was no
difference in the response of recipients of once or twice-absorbed
serum from OVA-fed mice compared to their controls which had received
twice-absorbed serum from saline-fed mice.
6.6 Immunogenicity in vitro of Gut-Processed OVA
Groups of BDFI mice were fed either 0.2 ml saline or 25 mg OVA
i.g.. They were bled out 1 hour after feeding, the sera were pooled
within groups and the concentration of OVA assayed by ELISA. The
standard curve for this assay is shown in figure 15 and the
relationships between 0D 405 nm and log^Q ^VA concentration was linear
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FIGURE 14
Systemic humoral and cell-mediated responses of recipients of
serum from saline or OVA fed mice: Effects of incubating serum
with anti-OVA.
Serum was collected from mice 1 hr after feeding.
Antibody (IgG) was measured by ELISA.
DTH was measured by footpad swelling 24 hrs after antigen challenge.
Responses were assayed 21 days after immunization.
Recipients were injected with serum from donors treated as shown
and were immunized 1 week later.
The term "abs" (absorbed, refers to sera which were incubated with
the immunoadsorbent S4B-anti-0VA).
= 0.99). The reading obtained for serum from OVA-fed mice falls in
this range as shown on the graph and corresponds to & value of
40 ng/ml.
As a source of primed cells for culture with gut-processed OVA,
BDFI mice were footpad-immunized with 100 jig OVA in FCA. Three weeks
later they were killed and cell suspensions made from the draining
lymph nodes.
The optimum antigen dose for T cell-dependent antigen-driven
blast transformation was 1.25 mg/ml OVA, that is, 250 jig OVA per well.
The amount of OVA present in the serum after feeding was only 40 ng
per ml. Therefore, the culture plate included wells containing; cells
only, cells + PHA as a positive control, cells + 250 jig OVA, cells +
10 pi serum from OVA-fed mice (this contained 40 ng gut-processed OVA
per ml), and cells + 10 jil of normal mouse serum containing native OVA
at a concentration of 40 ng per ml in order to compare any
transformation with gut-processed OVA to an appropriate dose of native
OVA. Cells + 10 yul normal mouse serum were also included to isolate
the effect of homologous serum proteins on cells in culture.
In an effort to increase the dose of gut-processed OVA presented
to cells in vitro, serum from OVA-fed mice was concentrated using
ultrafiltration membranes and the effective OVA dose calculated by
means of a concentration factor as shown in figure 15. Increasing
volumes of concentrated serum were added to cultures and cultures with
corresponding amounts of concentrated normal mouse serum were included
as controls. The results are summarised in table 7.
The response of OVA-primed cells to a 250 jig dose of OVA was
positive as expected with a mean cpm of 2953 + 1235 (P ( 0.02
compared to unstimulated cells). There was no in vitro response to
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FIGURE 15
Standard curve of ELISA for OVA concentration.
The reading for serum from OVA fed mice is indicated by broken lines.
The concentration of OVA is found by taking the antilog of 1.6,' 40 ng/ml.
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After Ultrafiltration






Amount of OVA in neat serum
(measured by ELISA) 40 ng/ml
Amount of OVA in concentrated serum
= 40 x 3.6 ng/ml
= 144 ng/ml
Therefore,
10 Ail concentrated serum contains 1.44 ng OVA
25 /il concentrated serum contains 3.6 ng OVA
50/il concentrated serum contains 7.2 ng OVA
After ultrafiltration of normal mouse serum.
Volume of concentrate = 0.7 ml

















Cultures Mean cpm + s.e. Index P Value
PHA 2313 + 526 6.7 0.025
250 ug OVA 2953 + 1235 8.6 0.02
- 345 + 327 1 -
0.4 ng "processed" OVA 34 + 8 0.1 N. S.
0.4 ng OVA in NMS 52 + 47 0.15 N. S.
10 ^1 NMS 20 + 15 0.06 N. S.
1.44 ng "processed ' OVA 7 + 8 0.02 \
10 ul concentrated NMS 64 + 63 0.18
> N. S.
3.6 ng "processed" OVA 16 + 17 0.05 \
25 ^ul concentrated NMS 30 + 21 0.09 f N. S.
7.2 jil "processed" OVA 8 + 4 0.02
50 ^ul concentrated NMS 8 + 1 0.009
\ N. S.
TABLE 7
Responses of OVA-primed Lymphocytes to Gut-Processed OVA in vitro
Normal mouse serum or serum containing gut-processed OVA was added
to cells obtained from BDFI mice 21 days after immunization with OVA.
serum from OVA-fed mice which contained 0.4 ng OVA, nor to 0.4 ng
native OVA dissolved in normal mouse serum (P / o.2 in each case).
Normal mouse serum itself induced no in vitro response.
Sera which were concentrated before being added to cultures in
increasing amount produced no in vitro response and the response of
cells given concentrated normal mouse serum was no different from
cells given concentrated OVA-containing serum.
6.7 Conclusions
Suppression of DTH in recipients of serum from OVA-fed mice is
abrogated if the serum is treated with the immunoadsorbent
S4B-anti-0VA prior to transfer.
An ELISA which detects OVA by its binding to anti-OVA antibody,
confirmed the presence of OVA in the serum after feeding and
demonstrated the removal of immunoreactive OVA from serum by
S4B-anti-0VA.
Taken together, these observations suggest that the tolerogen
present in mouse serum 1 hour after feeding is OVA and that it
possesses 3-dimensional conformation for B cell recognition via
antibody. The humoral antibody response in recipients of serum from
OVA-fed mice was lower than controls in this experiment (P ^ 0.05),
and might indicate that a critical dose of antigen is required for the
suppression of antibody responses by serum tolerogen.
Serum from OVA-fed mice was unable to stimulate OVA-primed lymph
node cells to proliferate in a T-dependent lymphocyte transformation
test. This may well have been due to the low dose of OVA present in
the cultures as even when the serum was highly concentrated, the
maximum antigen dose reached was only 7.2 ng. It would therefore be
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unwise to conclude from these results that T helper cells do not
recognise determinants on OVA which has been absorbed into the
circulation after feeding.
CHAPTER 7
SIZE, DISTRIBUTION AND EFFECT
OF OVA FRAGMENTS GENERATED BY
G U T - P R 0 C E S S I N G
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7.1 Introduction
The previous chapter demonstrated that the tolerogenicity of
whole serum collected one hour after an OVA feed is associated with
possession of determinants for anti-OVA antibody. However, there
still remained many unanswered questions pertaining to this
serum-borne tolerogen.
Details of the distribution and molecular size of the tolerogenic
moiety in serum would be of interest: Is the tolerogen a single
structure or is there a range of various fragments of OVA of differing
size and immunogenicity present in the serum? Together with the
antigen which is detected in serum by antibody, are there also
fragments of OVA which are not capable of being found by antibody but
can be recognized by T cells? Do small pieces of OVA molecules bind
to serum (self) proteins and thus present as large molecules bearing
OVA determinants or as antigen in the context of self determinants?
It is feasible that while the dominating effect of processed OVA in
the whole serum is to suppress cell-mediated immunity, the effect of
these hypothetical OVA fragments in isolation may be to induce quite
different immune responses.
This theory is not unprecedented as other workers have shown
previously that the immune response to a particular antigen can be
altered by changing the structure of the antigen (Chapter 1, section
1.3). Of particular interest is the work of Michael et al (1981)
where peptic digestion of BSA in vitro produced fragments of varying
molecular weights and antigenicity, the higher molecular weight
fragments which were produced could be bound by anti-BSA antibody,and
a low molecular weight fragment was also produced which did not bind to
antibody but which induced suppressor T ceils in mice. This
suppressor fragment could exert a suppressive effect on B cells when
conjugated to mouse gamma globulin.
If a similar mixture of OVA fragments is generated by
gut-processing, the isolation and both structural and functional
investigation of these fragments has potential for gaining insight
into the immuno-regulatory mechanisms induced by feeding OVA and also
for gaining information in general about mechanisms of antigen
recognition by cells of the immune system.
In the first steps towards this end, a series of experiments was
devised where serum containing gut-processed antigen was fractionated
by gel filtration to separate proteins on the basis of molecular
weight. High, medium and low molecular weight fractions were obtained
and assayed for total protein content, the presence of OVA with
determinants for anti-OVA and any. effect in vivo on the immune system.
Such an effect of a fraction could therefore be traced to molecules
within a known molecular weight range and to whether or not the effect
was synonymous with the presence of determinants recognized by
antibody.
7.2 Fractionation of Serum Proteins By Gel Filtration
Mice were fed either 0.2 ml saline or 25 mg OVA and were bled out
1 hour after feeding. The pooled sera from each group were then
fractionated on a Sephacryl column in order to separate the serum
proteins on the basis of molecular weight. Details of the column, its
calibration and the fractionation procedure are given in chapter 2
(Materials and Methods, Section (c)).
Samples were collected from the column in 3 ml volumes and pooled
into 3 major fractions: A high molecular weight fraction, FI,
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containing all serum proteins with molecular weights greater than
100,000 and therefore including the serum proteins macroglobulin,
immunoglobulin A and large lipoproteins; a "medium" molecular weight
fraction, FII, which was selected to contain proteins within
approximately the same molecular weight range as native OVA; and a low
molecular weight fraction, FI, which contained any proteins of
molecular weight less than that of native OVA down to the total
elution point of the column where very small molecules of 1 or 2 amino
acids are eluted. Figure 17 shows the optical density profiles at 206
nm of normal mouse serum proteins with the position of OVA (molecular
weight = 43,500) and glycyl-tyrosine (molecular weight = 238)
superimposed. The positions of fraction boundaries are also
indicated.
Fractions I, II, and III thus obtained were concentrated back to
the original serum pool volume by ultrafiltration and were dialysed to
remove sodium azide which was present in the column gel buffer.
7.3 Protein and OVA Content of Fractions
Aliquots of serum fractions were assayed for total protein
concentration using the method of Lowry and also for immunoreactive
OVA by ELISA. The results of these tests are summarised in table 8
together with values obtained for whole normal and OVA-fed mouse
serum.
The total protein content of serum from both saline and OVA-fed
mice was located in fractions I and II. No protein was detected in
the low molecular weight fraction from either saline or OVA-fed mice.
OVA was detected by antibody (in an ELISA) in whole serum of
OVA-fed mice and in fraction II of this serum. OVA was not detected
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FIGURE 17
Elution profiles of normal mouse serum, OVA and glycyl-tyrosine.
These proteins were eluted from a gel filtration column on the basis
of molecular weight. Fractions of serum were selected for transfer
experiments. Fraction boundaries are indicated by broken lines,
gly-tyr = glycyl tyrosine.
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NMS SFS SFS SFS OFS OFS OFS OFS
Whole FI FII Fill Whole FI FII Fill
Protein
(mg/ml) 32 6.4 25 neg 52.6 7.7 26.3 neg
OVA
» (ng/ml) neg * neg neg 38 neg 35 neg
TABLE 8
Estimates of Protein and OVA content in serum and serum fractions of
Saline (SFS) and OVA fed (OFS) mice.
Serum was collected from BDFI mice 1 hr after either Sal or OVA feeding.
Serum was fractionated by gel filtration on S200 Sephacryl.
Protein was estimated by Lowry, OVA by ELISA.
* Sample was contaminated before ELISA could be carried out.
1
in either FI or Fill from OVA-fed mice or in any of the samples from
saline-fed mice.
7.4 Immunogenicity of Serum Fractions in vivo
The serum fractions obtained in 7.2 above were tested in vivo for
any effect on immunoregulation within the usual immunization regimen.
That is, 0.8 ml serum fraction was injected i.p. into recipients which
were immunized with 100 ^ig OVA/FCA one week later and then bled and
DTH-skintested 3 weeks after immunization.
In this experiment, mice were also bled just prior to
immunization in order to determine whether a humoral response had been
mounted to the ingested, absorbed antigen in the serum fraction.
Products of the host response to orally administered antigen have been
previously postulated, as being responsible for oral tolerance
induction (Andre" et al, 1975).
The humoral antibody response in serum fraction recipients
immediately before, and 3 weeks after immunization are shown in figure
18. The response of mice injected i.p. with 0.8 ml saline 1 week
prior to OVA immunization is included as an illustration of a typical
antibody response. Pre-immunization antibody levels were negligible
and showed that host antibody was not produced by an injection of
serum fraction per se. Three weeks after immunization, the antibody
response in all groups was positive and no significant difference was
observed when recipients of "OVA-fed" fractions were compared to their
appropriate "saline-fed" controls.
The DTH response in recipients of serum fractions from saline-fed
mice were positive, as illustrated in figure 19 and a typical positive
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FIGURE 18
Pre and post-immunization antibody response in recipients of serum
fractions from saline or OVA fed mice.
Serum was collected 1 hr after feeding and fractionated by gel
filtration.
Recipients were injected with serum fractions from donors treated as
shown and immunized with OVA 1 week later. The group indicated
"(saline i.p.)" was injected with saline only and represents a normal
positive response. Antibody (IgG) was measured by ELISA (OD 405 nm)
21 days after immunization.
CD





















(saline Lp) Sal fed OVAfed Sal fed OVAfed Sal fed OVAfed SERUM
FI FI FH FII Fill Fin SOURCE
Cell-mediated response in recipients of serum fractions from saline
or OVA fed mice.
Serum was collected 1 hr after feeding and fractionated by gel
filtration.
Recipients were injected with serum fractions from donors treated as
shown and immunized with OVA 1 week later. The group indicated
"(saline i.p.)" was injected with saline only and represents a normal
positive response.
DTH was measured by footpad swelling 24 hrs after antigen challenge.
The response was assayed 21 days after immunization.
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FIGURE 19
response was suppressed in recipients of serum fraction II from
OVA-fed mice (P ^ 0.01 compared to "saline-fed" fraction II) Serum
fractions I and III from OVA-fed mice did not induce significant
suppression but produced lower DTH responses than those fractions from
saline-fed mice.
7.5 Conclusions
The analysis of serum fractions revealed that no protein was
detectable by Lowry technique in the low molecular weight fraction,
Fill, of serum from saline-fed mice as expected. The identical result
obtained with serum from OVA-fed mice implies that within the
limitations of a Lowry assay, small fragments of OVA molecules are not
present in serum at 1 hour after OVA feeding. Protein was detected in
the high and "medium" molecular weight fractions of serum from both
saline and OVA-fed mice. Ovalbumin however, was detected in FII of
OVA-fed mice only.
At this stage, two possible hypotheses are presented I OVA
present in serum is in the fraction corresponding to native OVA and
can be detected by antibody in the ELISA, or OVA which is not
recognised by antibody is present in fraction I (high molecular
weight).
On transfer into recipients, serum fractions did not suppress the
humoral anti-OVA response of recipients. This is consistent with
results obtained previously using whole serum.
Fraction II from OVA-fed mice suppressed DTH in recipients.
Taken together with the analysis of fraction II by Lowry and ELISA
techniques, this is consistent with the hypothesis that suppression of
DTH by this fraction is due to the presence of OVA, bearing
determinants for anti-OVA antibody and having the same or
approximately the same molecular weight as native OVA.
Fraction I and III from OVA-fed mice resulted in an observable
lessening of the DTH response in recipients. Whilst not significant,
this decrease in DTH does not entirely rule out the possibility of
antigen being present in these fractions which, in the case of
fraction III is not detected possibly by virtue of any of the
following qualities; the molecule or fragment is too small or present
in a concentration which is too low for its detection but which is
still relevant in vivo or perhaps is lacking in the amino acids
phenylalanine, tyrosine or tryptophan upon which detection in a Lowry
spectrofluorometric assay depends. A lack of B cell determinants
would explain the absence of immunoreactive OVA in both fractions I
and III but this does not rule out the possible presence of
immunologically active antigen in these fractions.
The effect of fraction II, suppression of DTH, appears to be







Previous work described in this thesis (Chapters 4, 5, 6 and 7)
investigated the nature and immunological properties of OVA which had
been absorbed across the intestinal tract into the circulation. The
purpose of the experiments described in this chapter was to establish
the role of the intestine and its associated immune system in
generating immuno-regulatory antigen in the serum by examining the
effect of intestinal damage on the production of tolerogenic OVA in
the serum after feeding.
Whole-body irradiation at a lethal dose of 1,000 rads was chosen
as a method of damaging the gut. The effects of ionizing radiation on
lymphocytes and on the intestinal epithelium are well-documented and
were discussed in Chapter 1 of this thesis. The major effects of
exposing the intestine to irradiation are lymphoid depletion with
damage to the absorptive surface of villi followed by a period of
regeneration when many new enterocytes are dividing in crypts and
replacing the dead or damaged cells on villi.
The object of the following experiments was to study antigen
processing in mice with intestinal damage in order to test the
hypothesis that damage to the intestine alters the immunological
properties of circulating gut-derived antigen. These in vivo
experiments were carried out in parallel with analysis of body weight
and intestinal histology and morphometry to determine the degree of
radiation damage at 2 time-points following irradiation and also with
ELISA tests on the serum of irradiated mice to assess absorptive
function in the damaged intestine. Finally, the relevance of lymphoid
cells to gut-processing was studied in irradiated mice which were
reconstituted with spleen cells. This was an extensive study
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involving large numbers of animals and was carried out in
collaboration with Dr Stephan Strobel.
8.2 Experimental Design
Groups of BDFI mice were either left untreated or else given a
total dose of 1,000 rads whole-body irradiation from an x-ray source.
At 2 or 5 days after irradiation, the mice were weighed, given a
single intragastric feed of either 25 mg OVA or 0.2 ml saline and were
bled out 1 hour later. At this point, sections of jejunum were
obtained and processed for histology and an aliquot of serum reserved
for testing in an ELISA to detect OVA.
The remaining sera were pooled according to experimental groups
and 0.8 ml serum injected i.p. into naive syngeneic recipients. These
mice were immunized 1 week later with 100 yug 0VA/FCA and were bled for
serum antibody measurement and DTH-skintested three weeks later.
In experiments where mice were to be reconstituted with spleen
0
cells, an injection of 25 x 10 naive syngeneic spleen cells in 0.05
ml RPMI 1640 medium was given i.v. within three hours of irradiation.
8.3 Effects of Irradiation in BDFI Mice
The mice lost weight following irradiation as shown in figure 20
and also exhibited changes in their gross physical appearance. Two
days after irradiation the mice were quiet and subdued and by 5 days
post-irradiation were quite lethargic and dehydrated, with diarrhoea.
Less serum was obtained from these dehydrated animals.
At post mortem, the intestines of irradiated mice were very thin
and shiny 'in appearance. Only tiny Peyer's patches were visible at 2




















Effect of irradiation on weight of BDFI mice.
Mice were weighed before and at 2 and 5 days after 1000R whole-body
irradiation.
severe lymphoid depletion had occurred in the gut-associated lymphoid
tissue.
Histology of jejunal sections of gut, revealed that a significant
reduction in villus length, together with crypt hypoplasia had
occurred at 2 days after irradiation. The villus length was restored
to normal by 5 days, and the crypts were longer than normal at this
time indicating that the gut epithelium was in a state of
regeneration. These points are illustrated in figure 21.
In addition to these morphometric changes in the appearance of
the gut, the numbers of intraepithelial lymphocytes (IELs) decreased
with time after irradiation, as shown in table 9. This agrees with
the previous suggestion of lymphoid depletion in the GALT based on
gross intestinal appearance.
8.4 Effects of Irradiation Damage on Intestinal Antigen Processing
Figure 22 shows the humoral antibody and DTH responses in
recipients of serum from saline or OVA-fed mice which were either
untreated or irradiated 2 or 5 days before feeding. This experiment
is referred to as Series 1 in illustrations.
The antibody responses of all recipient groups were normal. On
the other hand, while transfer of serum from non-irradiated OVA-fed
mice suppressed the DTH response of recipients as is usual in an
experiment of this nature, serum from both groups of irradiated,
OVA-fed donors did not induce suppression of DTH in recipients and no
significant difference was observed between these and recipients of
serum from irradiated, saline-fed donors.
The OVA concentration in donor mouse serum was assayed in an





























Effect of irradiation on jejunal villi and crypts of BDFI mice.
Measurements of villus and crypt length were taken from samples of
jejunum collected before and at 2 and 5 days after 1000R whole-body
irradiation.






Series 1 11.3 + 0.9 7.0 + 6.8 4.4 + 0.91
(n = 5) (n = 6) (n = 5)
TABLE 9
Effect of irradiation on numbers of jejunal intraepithelial lymphocytes
in BDFI mice.



































Systemic humoral and cell-mediated responses of recipients of serum
from saline or OVA fed donors: Effects of irradiation of donors.
Antibody (IgG) was measured by ELISA (OD 405 nm).
DTK was measured by footpad swelling 24 hrs after antigen challenge.
Responses were assayed 21 days after OVA immunization.
SERIES 1: Recipients were injected with serum collected from donor
mice one hour after sal o r OVA feeding as indicated on day 0
and were immunized with OVA 1 week later. Donors were either
previously untreated or had been irradiated 2 ( ^d-2)
















OVA (by ELISA) in Serum of BDFI Mice (each mouse fed 25 mg OVA one hour
previously)
Mice were given 1000 rads whole-body irradiation.
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than the non-irradiated controls (Table 10). Hence the absence of
suppression of DTH in recipients of serum from irradiated mice was not
due to any lack of ELISA-detectable OVA in the serum.
8.5 Effects of Irradiation and Spleen Cell Reconstitution on
Intestinal Antigen Processing
Ovalbumin which was transferred in the serum of irradiated mice
was not tolerogenic (Series 1). In order to examine the hypothesis
that this had occurred as a result of the severe lymphoid depletion in
irradiated mice, a serum transfer experiment was devised using, as
serum donors, irradiated mice which were reconstituted with spleen
cells on the day of irradiation (Series 2). Serum recipients were
injected, immunized and challenged in the usual manner.
Figure 23 shows the mean body weight of donor mice before
irradiation and at 2 and 5 days after irradiation and reconstitution.
Alongside these values are the mean body weights of donor.mice from
Series 1. The pattern of weight loss following irradiation was
identical regardless of whether reconstitution had taken place. It is
worth noting that reconstituted mice also had improved general
appearance with the only sign of dehydration seen at 5 days in some of
the mice who presented with slightly scruffy coats.
The serum antibody and DTH responses of serum recipients in
Series 2 are illustrated in figure 24. The results once again reveal
no reduction in humoral antibody levels following serum transfer, and
recipients of serum from non-irradiated OVA-fed mice again showed a
suppressed DTH response (P ^ 0.05 compared to non-irradiated
controls).























Effect of irradiation + reconstitution on weight of BDFI mice.
Mice were weighed before and at 2 and 5 days afterfc1000R whole-body
irradiation.
Shaded symbols represent mice which were irradiated and then reconstituted
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Systemic humoral and cell-mediated responses of recipients of serum
from saline or OVA fed donors: Effects of irradiation and reconstitution
of donors.
Antibody (IgG) was measured by ELISA (OD 405 nm).
DTH was measured by footpad swelling 24 hrs after antigen challenge.
Responses were assayed 21 days after OVA immunization.
SERIES 2: Recipients were injected with serum collected from donor
mice one hour after sal or OVA feeding as indicated, on day
0 and were immunized with OVA 1 week later.
Donors were either previously untreated or had been irradiated
and reconstituted with 25 x 10 spleen cells 2 (t d-2)
(recon. )
or 5 ( J.d-5) days before feeding.
(recon.)
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of serum from OVA-fed mice which had been irradiated and reconstituted
with spleen cells. Reconstitution with normal spleen cells following
irradiation had restored the ability of donor mice to transfer
tolerance for DTH with serum after OVA feeding.
This experiment was then repeated in combination with series 1,
that is, using non-reconstituted mice, in order to obtain a more
meaningful comparison of the effects of spleen cell reconstitution.
Also in this combined test, which was called Series 3, serum obtained
from donors was analysed by ELISA for immunoreactive OVA.
8.6 Comparison of the Effects of Irradiation of Serum Donors With and
Without Spleen Cell Reconstitution
Groups of donor mice were irradiated and reconstituted with
normal spleen cells in RPMI 1640 medium, or irradiated and
sham-reconstituted with medium or else left untreated. Two days after
irradiation, the mice were fed OVA and bled out after 1 hour at which
point jejunal sections were collected and processed for histology.
The pooled serum was tested for OVA and transferred into recipients
which were later immunized and challenged with OVA as before. Note
that only 1 post-irradiation time-point was selected. Since the effect
of irradiation on serum-transferrable tolerance had been the same at both
2 and 5 days after irradiation, this practical step was taken to reduce
the large number of animals required for the experiment.
The number of intraepithelial lymphocytes per 100 epithelial
cells in jejunum was calculated for 2 donor mice per group and are
shown in table II together with the IEL counts obtained in Series 1.
The results indicate that the numbers of IELs decreased in jejunum
following irradiation, as was the case in Series 1, and that the
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numbers of these cells approached normal in irradiated mice which were
reconstituted with spleen cells.
The humoral antibody and DTH responses of serum recipients in
this combination experiment are summarised in figure 25. Serum
antibody levels in recipients are not suppressed by serum transfer and
are even elevated in three of the groups. The DTH response of
recipients confirms the previous finding: Mice injected with serum
from OVA-fed donors have suppressed DTH, although in this one
experiment, the difference between this and the appropriate control
group (recipients of serum from saline-fed donors) is not significant;
irradiated donors do not transfer tolerance for DTH with serum after
OVA-feeding but reconstituted irradiated donors do transfer tolerance
with serum (P / 0.05 compared to recipients of serum from irradiated
and reconstituted donors).
The OVA content of pooled sera from this test was measured in an
ELISA and compared with the values obtained in the first experiment
using only irradiated mice, (Series 1). The results of these assays
are given in table 12 which reveals that the in vivo immunological
effects of these sera (figures 22 and 25), occur over a wide range of
OVA concentrations in serum and that overlap occurs in the amount of
OVA present in "tolerizing" serum and "non-tolerizing" serum. For
this reason it seems unlikely that the effects of irradiation with and
without spleen cell reconstitution are the result of differences in
the amount of OVA transferred in the serum.
8.7 Conclusions
Whole body irradiation removes the ability of mice to process OVA
after feeding and render it tolerogenic. This is not due to a lack of
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Effect of irradiation with and without reconstitution on numbers of
jejunal intraepithelial lymphocytes in BDFI mice.
Mice were given 1000 rads whole-body irradiation.
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FIGURE 25
Systemic humoral and cell-mediated responses of recipients of serum
from saline or OVA fed donors: Effects of irradiation + reconstitution
of donors.
Antibody (IgG) was measured by ELISA (OD 405 nm).
DTH was measured by footpad swelling 24 hrs after antigen challenge.
Responses were assayed 21 days after OVA immunization.
SERIES 3: Recipients were injected with serum collected from donor
mice one hour after sal or OVA feeding as indicated, on day
0 and were immunized with OVA 1 week later.
Donors were either previously untreated, or irradiated 2
days before feeding ij.d-2), or irradiated and reconstituted

















OVA(by ELISA) in Serum of BDFI mice (each mouse fed 25 mg OVA one hour
previously)
Mice were given 1000rads whole-body irradiation as indicated.
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antigen in the circulation of irradiated mice as an ELISA of OVA
content in their serum revealed, in some cases, large amounts of
immunoreactive OVA, nor is the lack of tolerance due to an alteration
in the quantity of OVA present in the serum as the same in vivo effect
is observed over a wide range of ELISA-detectable OVA concentrations
in the serum of irradiated and non-irradiated mice (table 12). In
addition, the effect of irradiation on serum-transferrable tolerance
is found when the intestinal crypts are in either a state of
hypoplasia (2 days post-irradiation) or hyperplasia (5 days
post-irradiation) and so seems not related to a specific type of
abnormality in the gut.
The irradiated mice were in a state of intestinal lymphoid
depletion with sharply decreased IEL counts. After reconstitution
with syngeneic spleen cells on the day of irradiation, the numbers of
IELs in jejunum were restored to normal. Reconstitution with lymphoid
cells also restored the ability of the intestine to process OVA such
that the protein was once more tolerogenic in serum. As in the case
of non-reconstituted irradiated mice, the presence or absence of
tolerogenic OVA in the serum after feeding could not be correlated
with the quantity of antigen in the circulation. I would suggest
rather, that changes occur in the intrinsic physico-chemical
properties of ovalbumin protein during intestinal processing and that
this antigen processing is linked to the presence of a lymphoid
compartment in the gut. In these serum transfer donors which ar# bled
out after feeding, the lymphoid cells are not required to respond to
OVA in order for tolerogen (for DTH) to be produced in the serum but
are rather required as a facet of normal gut function in order for
tolerogenic OVA to be present in the systemic circulation.
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Further to this is the observation that irradiated and
reconstituted mice continued to lose weight in the manner of
non-reconstituted animals and suggests that restoration of gut antigen
processing is not merely due to improvement in the general health and
well-being of the irradiated mice after spleen cell reconstitution but
is due to the presence of healthy lymphoid cells. Such an association
between the gut and GALT would be a natural link between normal
intestinal function and immune regulation induced by feeding.
«
c h a p t f r q
general discussion
9.1 Introduction
The induction of specific systemic immunological tolerance in
mice by feeding a single dose of the soluble protein ovalbumin has
been the subject of study in this thesis. The phenomenon of oral
tolerance is a phenotypic response, that is, the net host response
occurring as the result of inter-reactions between the intestinal
tract, the gut-associated lymphoid tissue and the systemic immune
system.
In the search for an underlying mechanism for this phenotypic
response, many workers have studied only a single aspect of the
response and often by indirect methods such as plaque-forming cell
(PFC) assays. Counts of the numbers of plaque-forming cells in spleen
and GALT bearing surface antibody of particular isotypes have
provided information about the regulation of B cells following antigen
feeding.
Mattingly and Waksman transferred into recipient animals, cells
from Peyer's patches, mesenteric lymph nodes, spleen and thymus of
rats at various times after feeding sheep erythrocytes. They
described suppressor cells for IgM and IgG PFC responses which were
generated in the GALT of donor rats after 2 days of antigen feeding
and then migrated to the spleen and thymus where they were found at 4
days after antigen feeding (Mattingly and Waksman 1978).
Similar work in mice showed that the continuous feeding of
heterologous erythrocytes initially primed the IgA and Ig(? PFC
response in the spleen but suppressed the splenic IgM PFC response
(Kagnoff, 1978 b ). In addition, suppression of IgG and IgA PFC
responses by Peyer's patch cells was found to be due to the presence
of suppressor T cells which were effectively masking the concomitant
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priming of B cells which could respond when the suppressor population
was removed (MacDonald, 1983).
Evidence of isotype-specific regulation of B cells by feeding a
protein antigen came from Richman et al, (1981) who demonstrated the
presence of both IgA-specific helper T cells and IgG-specific
suppressor T cells present in Peyer's patches within 1 day of feeding.
These cells subsequently migrated to the mesenteric lymph nodes where
they were detected at 3 days after feeding. After this time the
IgG-specific suppressor cells were found in the spleen but the helper
cells for IgA did not apparently leave the GALT.
Whilst these experiments have highlighted particular regulatory
mechanisms induced by antigen feeding it is not clear how well the PFC
response reflects the net humoral antibody response. On this point it
is interesting to note that circulating antibody can be detected in
the absence of plaque-forming cells (Thomas and Parrot, 1974).
Many other workers have measured circulating specific antibody
following antigen feeding and the suppression of the humoral response
following the ingestion of antigen is a well documented phenomenon.
However experiments described in this thesis have shown that tolerance
for cell-mediated immunity can occur in the presence of a normal serum
antibody response (Chapter 4) and emphasises the importance of
experiments designed to assay more than just one component of the
systemic response.
In the course of designing such experiments, difficulties in
assessing the regulation of cell-mediated immunity arise. The use of
in vitro techniques such as measuring the proliferation of cells in
response to a specific antigen have been useful in defining cells
capable of mediating the regulation of systemic immunity by feeding.
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The experiments of Miller and Hanson (1979) on BDFI mice fed with
OVA demonstrated that suppression of systemic DTH, measured in vivo as
an ear swelling response, correlated well with the in vitro
proliferative response of ceils from peripheral lymph nodes. In my
experiments (Chapter 3) I was unable to correlate the in vitro
proliferative response of BDFI mice which were fed OVA with the in
vivo expression of DTH in a footpad skintest. That is, despite the
presence of a suppressed DTH response in vivo, I was unable to discern
a concomitant significant decrease in the in vitro response. Whether
this result was due to differences in technique as discussed in
chapter 3, or whether different populations of cells are involved in
ear swelling and footpad thickening in response to local antigen
injection is unknown at present.
Selective depletion of cells in culture has been used as a tool
to identify subsets of regulatory cells operating in vitro. For
example, by removing T cell sub-populations from peripheral lymph
node cells, Silverman et al (1983) were able to show that suppression
of the proliferative response of lymph node cells from mice fed with
BSA prior to immunization was mediated by a T cell bearing Ly 1+ 2
surface antigens.
Mucosal immunization with a viral antigen also induces production
of Ly 1 2 suppressor T cells which suppress DTH when transferred in
. . + —
vivo (Liew and Russell, 1980) and although Ly 1 2 is not a surface
marker traditionally associated with suppressor cells, whicrf were
thought to be of Ly 2+ phenotype (Feldmann and Kontiainen, 1976), this
may represent a particular regulatory cell induced by feeding.
Results from in vitro experiments must be applied in vivo with
caution, since it is by no means established that a particular
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cellular mechanism which operates in vitro, perhaps only as described
above, following the removal or the addition of other regulatory
cells, is the responsible mechanism for an in vivo phenotypic response
or even that such a mechanism operates at all in vivo since
observations of a state of tolerance do not always correlate with
studies of individual cellular function (Parks and Weigle, 1980 a ;
Hanson and Miller, 1982).
Therefore, while in vitro studies of the sort discussed above are
useful in defining isolated mechanisms of immune regulation,
experiments to assess the in vivo responsiveness of whole animals
(although they are often time-consuming to perform and complex to
design and interpret) are still necessary if a logical arrangement of
the various regulatory mechanisms described so far into a net
phenotypic response is to be achieved.
Using the serum transfer protocol, I examined the role of the gut
in the induction of tolerance following antigen feeding by collecting
the antigen itself immediately after its passage across the gut
mucosa, and studying its behaviour both in vivo and immunochemically.
In these types of experiments it was possible to dissect out the
systemic component of the immune response to antigen entering the
circulation via the gut both in normal animals and in
immunologically-compromised ..hosts treated with cyclophosphamide.
In these experiments I adopted a protocol of measuring systemic
DTH and humoral antibody. With hindsight, it would also have be4en of
value to examine the isotype of antibody produced by serum recipients
since an overall positive presence of serum antibodies might mask the
suppression of a particular immunoglobulin isotype.
The ELISA for detecting OVA-specific antibody measured only IgG
m
anti-OVA. The indirect haemagglutination assay which I used at the
start of my project was time-consuming and required much larger sample
volumes than the ELISA but did offer the option of estimating the
relative amounts of IgG and mercaptoethanol-sensitive antibody
(presumed IgM). In order to detect antibody isotypes by ELISA it
would be necessary to develop a separate assay for each isotype using
specific anti-isotype antibodies for their detection. These assay
methods have recently been achieved in this laboratory and therefore
analysis of stored serum samples will be carried out in the coming
months.
The footpad skintest, which was my choice of method for measuring
systemic DTH, is a fairly crude, if simple, technique and should
ideally be used in conjunction with some other test of cell-mediated
immunity such as passive transfer of DTH effector cells plus antigen
into the footpad of a naive recipient mouse: The recipient acts
merely as a living incubator and cellular proliferation in response to
antigen is seen as an increase in footpad thickness (Kettman and
Mathews, 1976).
Another test of cell-mediated immunity is the in vitro cell
proliferation test. I attempted to use this assay in conjunction with
the DTH skintest but met with only limited success as I have already
described.
Using the footpad skintest for DTH, reproducible results can be
obtained with practise and partly for this reason it was importarft for
me to test that I could repeat the earlier established experiments of
Mowat (Mowat et al, 1982) in which mice were parenterally immunized
(positive for DTH), or were tolerized by feeding OVA (suppressed DTH),
or had oral tolerance abrogated by pretreatment with CY (positive for
DTH). I found that I was able to reproduce these results in BALB/c
mice (Chapter 3) and was therefore confident in my interpretation of
subsequent experiments involving skintesting for the estimation of
systemic DTH.
The importance of the intestine and its associated immune system
in the regulation of immunity by feeding was explored by studying the
intestinal handling of a protein antigen under normal and abnormal
conditions such as after CY treatment and following irradiation.
The antigen which I used was five times recrystallised ovalbumin
from chicken egg white (OVA) and there were inherent advantages in
using this protein. Since many other workers have studied the same
antigen, there exists a large body of published data for comparison
with my own work. In addition, although egg protein such as OVA was
not a typical dietary antigen for my experimental mice, it is of
interest that for many humans, egg albumin is a common dietary protein
and has been identified in egg white as a major allergen for humans
(Langeland, 1982). OVA is therefore of interest to workers studying
both human disease and animal models of immunity.
Many antigens commonly introduced into the intestine are not
protein, such as bacterial antigens for example, and so it would be
unwise to form a unifying hypothesis about the regulation of responses
by feeding "antigen" without considering that various types of antigen
are commonly encountered by the gut and may produce distinct patterns
of immunity. *
Even within the body of data relating to different protein
antigens used by other workers, results should not be compared without
realising that differences in protein structure may result in
differences in digestibility for instance, and in antigen processing
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by the intestine which can in turn influence the regulation of the
immune response to a particular protein. In the context of this
argument OVA may not be the most suitable protein to use in feeding
experiments as it has some distinctive properties such as being
heavily phosphorylated and bearing a large carbohydrate moiety which
make it rather unusual among proteins (Vadehra and Nath 1973).
However, in immunological experiments such as mine, it was vital to
introduce an antigen which had never been previously encountered by
the experimental mice and which was simple to dissove and feed in
measured doses and so for these reasons I made the decision to use
this readily available antigen.
A disadvantage in buying a commercially prepared antigen is the
risk of impurity. However, rabbit anti-OVA antiserum raised against
five times crystallised OVA formed a single precipitin line in agarose
gel when tested with OVA. Therefore, if five times crystallised OVA
is contaminated to a slight degree with other egg white proteins, I
was content that OVA was the immunodominant antigen and that the
effects I was observing were due to the immune response to OVA and
were not influenced to any noticeable extent by contaminants. I
certainly felt that in view of the time allotted for the project, the
size and number of experiments and the amount of antigen required,
that it would have been impractical to continually assess the purity
of my antigen or to attempt to purify OVA in the laboratory. I
compromised by always ordering from the same company and Always
ordering the same type of antigen preparation.
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9.2 Suppression of Cell-Mediated Immunity by Serum Transfer
In previous serum transfer experiments by other workers
investigating the suppression of antibody responses, various antigens
have been used including OVA and a particulate antigen, sheep
erythrocytes. Serum was collected at several different times after
antigen feeding; from 8 hours to 14 days, and a consistently negative
result was achieved in all cases. Serum transfer after antigen
feeding did not suppress antibody responses in recipients (Hanson et
al, 1979; Kagnoff, 1978 b ). The only report of the transfer of
tolerance by serum from mice given a single feed of OVA comes from my
own laboratory (Strobel et al, 1983).
After discussion with Dr Donald Hanson and based on his
experience with serum transfer experiments, serum was collected one
hour after feeding 25 mg OVA. This was a suitable period to allow for
gas,trie emptying and protein absorption to occur (D Hanson, personal
communication, 1980) and was a convenient interval in which to feed
several mice before it became necessary to bleed out the first mouse.
Serum obtained in this manner was capable of inducing specific
suppression of the cell-mediated arm of immunity.
The one hour post-feeding serum collection was used for all the
serum transfer experiments. This was done for practical reasons; a
serum transfer experiment, taking serum at a single time point
involved feeding and bleeding very large numbers of mice in order to
obtain enough serum and this part of the experiment took several
hours. It would have been unrealistic to attempt to collect sera at
different time points with the resources available including time and
technical assistance. However, in view of the data generated by these
experiments it would now be of great interest to examine the
immunological effects of sera obtained at other time points after
feeding.
The work of Swarbrick on the uptake of radiolabelled OVA after a
single feed suggested that absorption was biphasic with peaks in OVA
concentration at 45 minutes and at 70 minutes (Swarbrick, 1979). To
investigate the immunogenicity of absorbed antigen even at just these
two times would be of interest, as would a much later collection of
serum, perhaps not as late as 24 hours after feeding since by this
time there is evidence of a host immune response to the ingested
protein both from my own work (Chapter 3) and that of others
(Silverman et al, 1983), but certainly after several hours. The
relative amounts of postulated immunogenic and tolerogenic antigen
present in serum after feeding may well be quite different at
different times following antigen feeding and it would be interesting
to test the net immunological effect of any remaining antigen or
fragments of antigen.
The humoral antibody response was not suppressd by serum
transfer. This agrees with the published results just mentioned and
illustrates the importance of an experimental design which assesses
both the humoral and cell-mediated arms of an immune response.
In experiments where tolerance has been transferred by serum from
mice fed with several doses of a particulate antigen, the serum has
been found to contain either antibodies (Kagnoff 1978 c ) which may
even be anti-idiotypic in specificity (Kagnoff 1980), or immftne
complexes (Andre* et al, 1975). All of these are the result of host
immune responses directed against the fed antigen. In my experiments,
where serum was taken only one hour after feeding, it is unlikely that
any such products of an immune response could accumulate in this short
space of time.
Further evidence for this has come from experiments performed by
other workers in this laboratory: Mice were fed 25 mg OVA and were
bled out after one hour. Their serum was injected into naive
syngeneic recipients which were in turn bled 7 days later. Their
serum was then tested for the presence of anti-OVA antibodies. No
such antibodies were detected, and so mice injected with serum
containing gut-processed OVA did not mount an anti-OVA antibody
response, and more importantly, nor did they possess any antibodies
passively transferred with the serum of OVA-fed mice (Strobel et al,
1983). For this reason it seems unlikely that my observation of
tolerance transferred by serum from OVA-fed mice is due to the
transfer of products of a host immune response such as antibody or
immune complexes.
A somewhat unusual observation was the induction of tolerance for
CMI with serum from OVA-fed mice whilst humoral immunity in recipients
was apparently unaffected. This strengthens the theory that multiple
mechanisms are involved in immune regulation following antigen
feeding. In addition, serum-transferable tolerance for CMI is
abrogated if the recipients are injected with 100 mg/kg
cyclophosphamide 2 days prior to injection with serum. My initial
experiments with BDFI mice showed that the reversal of oral tolerance
by CY was restricted to the suppression of CMI (Chapter 3).
Previous work with CY, described in Chapter 1, has borne out the
particular effect of this drug on the regulation of cell-mediated
immunity by suppressor cells. Briefly, CY will reverse tolerance
which is caused by suppressor cells (Turk and Parker, 1982; Sy et al,
1977) and when used within the dose range of 20 - 200 mg/kg, has been
found to inhibit short-lived suppressor cells affecting DTH responses
(Diamantstein et al, 1981; Atallah et al, 1979).
My experiments, demonstrating the induction of tolerance in BDFI
mice by feeding 25 mg OVA and the restoration of DTH by CY
pretreatment have not shown, other than by inference, that suppressor
cells are responsible for the induction of oral tolerance and future
work involving cell transfers should clarify this. Miller and Hanson
(1979) were able to demonstrate by means of sequentially timed spleen
cell transfers from BDFI mice fed 20 mg OVA, that tolerance for DTH
was induced by suppressor cells acting on the afferent limb of the
response. In addition, work from this laboratory has shown that
treatment of serum donors with CY does not affect either the uptake of
antigen or the appearance of DTH tolerogen in the serum (Strobel et
al, 1983) and the morphological and histological studies of Mowat
(1981) showed that CY did not appear to alter epithelial cell
structure. This is strong evidence in favour of the hypothesis that
my observations of CY-sensitive tolerance for DTH, induced by an
injection of 0.8 ml serum collected one hour after OVA ingestion, is
due to the activation of a distinct class of suppressor cells which do
not act on antibody responses.
Whisler and Stobo have previously described a mouse suppressor
cell for DTH which did not inhibit plaque-forming cell responses
(Whisler and Stobo, 1978). In serum recipients which in my
experiments are injected with serum parenterally, such a suppressor
cell could presumably be activated at a site distant from the GALT.
Whether this is true of intact animals tolerized directly by feeding
antigen is uncertain.
BDFI mice fed with 25 mg OVA develop tolerance for both DTH and
humoral antibody responses. Collecting the antigen in serum one hour
after such an oral dose of OVA and transferring this into naive mice
effectively bisects the compound regulation induced by feeding. The
serum recipients are exposed to a tolerogenic stimulus for DTK but not
for antibody responses. This implies that antigen recognition in the
gut-associated immune system is necessary for the combined suppression
of both cell-mediated and humoral immunity.
I have already postulated a role for suppressor cells in the
induction of oral tolerance for CMI. When considering such
immunoregulatory cells in the immune system of the gut, there have
been several descriptions of GALT suppressor cells by other workers.
Ngan and Kind (1978) reported the presence of T cells in the Peyer's
patches and spleens of mice fed OVA which suppressed specific anti-OVA
IgE and IgG responses when transferred into recipients. They also
noted that Peyer's patch suppressor cells produced a more profound,
long lasting suppression than splenic suppressor cells. Cell transfer
experiments in rats fed with sheep erythrocytes also established the
presence, in Peyer's patches, of suppressor cells for IgM and IgG
responses to a particulate antigen and demonstrated GALT suppressor
cells for DTH responses (Mattingly and Waksman, 1978).
Later work by Challacombe and Tomasi (1980) demonstrated
suppression of CMI (measured as a proliferative response of cells in
vitro) in cells taken from GALT after feeding either protein or a
bacterial antigen. While the recent experiments of MacDonald shc4/ed
that in mice fed with sheep erythrocytes, B cells in Peyer's patches
were primed by the antigen but were unable to respond due to the
presence of suppressor T cells which prevented the generation of IgG
and IgA plaque-forming cells (MacDonald, 1983).
If such a regulatory mechanism exists in the Peyer's patches of
mice fed with OVA, and there is some evidence for suppressor cells
controlling at least IgG anti-OVA formation in mouse Peyer's patches
(Richman et al, 1981), it could be postulated that gu1>processd
antigen would tend to prime B cells and that these cells would be
inhibited by GALT suppressor cells. In serum transfer experiments,
where gut-processed antigen is injected i.p. such that Peyer's patch
suppressor cells for B cell responsiveness are not generated in
recipients, one might predict the already observed outcome of the
induction of a systemic humoral antibody response with the concomitant
induction of systemic suppressor cells for DTH responses. However, I
observed no evidence of priming for antibody responses by serum
transfer and the hypothesis would require to be tested by means of
experiments involving serum transfers followed by cell transfers in
combination.
Antigen dose is an important factor governing immune regulation
and so it is appropriate to consider the effective dose of OVA
presented to serum recipients in my experiments. An oral dose of 2 mg
OVA suppressed CMI but not antibody responses in BALB/c mice (Mowat et
al, 1982) and the difference in immunological outcome of oral versus
parenteral exposure to oxazolone had been attributed to a difference
in the amount of systemically available antigen in oxazolone-fed
animals which led to the induction of tolerance (Asherson et al,
1979). Likewise, the work of Hanson on the induction of antibftdy
tolerance to soluble proteins in newborn mice produced good evidence
that regulation of the antibody response was determined by the dose of
fed antigen; a small dose of 0.1 yug of HGG per gram body weight
resulted in priming while 1 /-ig/g produced no net effect and larger
doses of 10 - 1,000 ^ug/g induced tolerance (Hanson, 1981).
My experiments have shown that parenteral administration of
native OVA within a range of doses typically found in the circulation
after feeding (0.01 ^ig - 10 ^ig), does not induce tolerance or priming
for either DTH or antibody responses (Chapter 5), and measurements of
the amount of OVA present in tolerizing and non-tolerizing sera
(Chapter 8) revealed that there is no apparent relationship between
the amount of OVA transferred in serum and suppression of DTH.
However, the effect of large doses of gut-processed antigen on
antibody responses has not been tested, and while my results suggest
that the quantity of antigen transferred in serum after feeding is not
relevant to the induction of tolerance for DTH in recipients, it would
be interesting to examine whether a substantial increase (perhaps
1,000 yug) in the amount of gut-processed OVA transferred would induce
tolerance for antibody also.
The work of Miller et al (1979) on the induction of tolerance
with protein antigen coupled to syngeneic lymphoid cells had shown
that the route of parenteral antigen injection could influence the
immune response. Subcutaneous injection resulted in the antigen
reaching the circulation via lymphatic drainage, presumably being
exposed to cells of the immune system in lymph nodes, and tended to
induce immunological priming. On the other hand, antigen which was
injected intravenously preferentially induced tolerance. In my
experiments with a soluble protein antigen, I found no difference in
the response to a range of doses of native OVA whether administered
directly into the circulation by an i.v. injection or via the
intra-peritoneal route by which antigen may be cleared by a
combination of direct venous drainage or via lymphatic channels
(Chapter 5).
Similar doses of gut-processed OVA were injected i.p. in serum
transfer experiments and induced tolerance. It seems likely
therefore, that the induction of tolerance with serum containing
gut-processed soluble antigen is not dependent on whether the route of
injection is intravenous or intraperitoneal.
Other workers studying regulatory mechanisms induced in oral
tolerance have used various strains of mice for their experiments. In
the experiments described in Chapter 3 of this thesis, I repeated the
oral tolerance experiments of Mowat with BALB/c mice (Mowat et al,
1981) and used an identical protocol in BDFI mice to test the
induction of oral tolerance by a single feed of 25 mg OVA and the
sensitivity of this phenomenon to CY. Unlike BALB/c mice,
CY-sensitive suppression is restricted to DTH responses in the BDFI
strain. Oral tolerance for serum antibody production in these mice is
therefore resistant to CY and thus seems likely to be under the
control of a different regulatory mechanism in mice of this strain.
Strain-related differences in responsiveness to orally administered
antigen such as I observed between BALB/c mice and BDFI mice are not
well understood and highlight one of several areas of mucosal
immunology requiring further study.
In one recent report however, Stokes jet al compared antigen
absorption and oral tolerance induction in 3 genetically distinct
strains of mice. They found that not all strains exhibited immftne
exclusion to fed antigens after a previous oral immunization and that
immune exclusion and oral tolerance were not associated phenomena. In
addition, although all 3 strains tested were able to develop oral
tolerance to fed antigen, 2 of the strains were only made tolerant if
the antigen was fed continuously in the drinking water as opposed to
via a single intragastric intubation (Stokes et al, 1983).
A genetic basis for inter-strain differences in gut-related
immunity should not indicate a requirement for immunologists to design
experiments testing purely Ir gene function. Clearly, a difference in
intestinal function due to some other set of genes unrelated to the
immune system, perhaps influencing antigen handling in the gut, could
well affect the ultimate immune response to an ingested antigen.
In addition, strain differences in intestinal immunity could well
reflect differences in gut flora or susceptibility to enteric
infections such as viruses or protozoa for example. These situations
also might subsequently affect the net host response to antigen in the
intestine.
The sex or age of an animal may be related to oral tolerance and
although studies of immune regulation by feeding exist which describe
newborn animals, information is scarce regarding the influence of
ageing or gender on immune regulation by antigen feeding and further
study in this field also is obviously required.
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9.3 Nature of the Circulating Tolerogen Produced by Ovalbumin Feeding
The induction of tolerance by an i.p. injection of gut-processed
OVA in serum is not related to the effective systemic antigen dose,
nor is it associated with a particular route of injection. It is
probable that the nature or quality of gut-derived OVA is relevant to
its tolerogenic properties. The serum tolerogen could be produced by
physico-chemical alterations to the native protein in the intestine
occurring as part of the normal assimilation of exogenous proteins.
Examples of published data described in Chapter 1 have shown that
structural modification can dramatically alter immune responses to the
same antigens.
Systemic exposure to denatured and to deaggregated OVA over a
range of doses comparable with the concentration range of
gut-processed OVA in serum, revealed that processing of OVA after
feeding was not equivalant to protein denaturation since, unlike
gut-processed OVA, this form of antigen had no effect on the systemic
immune response to native OVA (Chapter 5). Previous work had shown
that denatured protein antigens were capable of modifying the immune
response directed against the native protein (Goetzl and Peters, 1972;
Takatsu and Ishizaka, 1975).
Deaggregated OVA on the other hand was a potent tolerogen and
this agrees with previous published data (Dresser, 1962; Golub and
Weigle, 1969). However, deaggregated OVA induced suppression of both
DTH and antibody whereas the gut-processed antigen normally only
induced tolerance for DTH. It seems unlikely therefore, that
gut-processed OVA is simply deaggregated OVA. Other workers have
shown that "impure" preparations of 'deaggregated proteins, that is
when the protein was not wholly deaggregated, were inefficient at
inducing tolerance for antibody production as macrophages were able to
process the contaminating "immunogenic moities" and stimulate an
antibody response (Lukic et al, 1975; Golub and Weigle, 1969). The
effects of these antigen preparations on cell-mediated immunity were
unfortunately not addressed by these papers. It is possible however,
that OVA contained in serum one hour after feeding behaves like a
preparation of OVA which is not entirely deaggregated. Thus it would
be tolerogenic for CMI due to deaggregation but perhaps unable to
induce tolerance for antibody due to the presence of non-deaggregated
OVA.
The failure of tolerance induction by OVA which was not fed, but
injected into the systemic circulation and transferred one hour later
with serum into recipients (Chapter 5) suggests that the tolerogen for
CMI in serum after OVA feeding is almost certainly a product of
intestinal function and is not produced after further systemic
processing in the donor. It is of course impossible to tell from my
experiments whether any further systemic processing of the tolerogen
occurs in the recipients.
Previous experiments of this type, known as "biologic filtration"
experiments, have shown the induction of tolerance for antibody
responses in rabbits by antigen after 48 hours previous systemic
filtration. In mice given antigen which had had 24 hours systemic
filtration, antibody tolerance was induced by the filtered antigen
which was less profound than that induced by an injection of native
antigen (Frei et al, 1965). Subsequent experiments in mice succeeded
in demonstrating that systemic filtration can produce a tolerogen for
antibody responses (Lukic et al, 1975). However, in my experiments,
serum tolerogen for CMI produced by OVA ingestion is present within
one hour of feeding and so seems not a product of systemic filtration
by macrophages. In addition, the extremely rapid clearance of OVA
from the circulation after feeding (Swarbrick, 1979) makes comparison
with experimental systemic filtration difficult.
Without more detailed immunochemical analysis there existed only
strong circumstantial evidence that the serum-borne tolerogen
generated by feeding OVA, which induced antigen-specific suppression
of DTH, was in fact antigen and not for instance, some other soluble
factor induced by feeding which acted in an antigen-specific manner.
The use of an ELISA technique confirmed the presence of OVA in the
serum of OVA-fed mice (Chapter 6). This technique avoided the
problems inherent with tracing radio-labelled proteins in serum
discussed in the introduction to this thesis, which were pointed out
in the experiments of Skogh (Skogh, 1982) and others (Udall et al,
1981). The ELISA was sensitive enough to detect nanogram quantities
of OVA and, since detection was via the binding of OVA to
affinity-purified anti-OVA IgG, also provided information about the
antigenic structure of OVA in serum after feeding; the protein
possessed antibody-binding sites or B cell recognition elements.
That this protein was in fact responsible for the tolerogenicity
of serum containing ELISA-detectable OVA was confirmed by experiments
where the tolerogenicity of serum from OVA-fed mice was removed after
absorption with anti-OVA bound to Sepharose. These experiments
illustrated that tolerogenic gut-processed OVA possessed structures
which B cells could recognise via antibody. The experiments of Endres
and Grey showed in vitro that suppressor T cells specific for native
OVA could recognise the same sorts of antigenic determinants on the
molecule as B cells (Endres and Grey, 1980 a ). Their experiments
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were based on the theory that suppressor T cells can be activated by
antigen without a requirement for antigen processing by accessory
cells. Gut-processed antigen could conceivably provide such a
stimulus for suppressor T cells since the tolerance induced by serum
transfer is CY-sensitive and almost certainly mediated by suppressor
cells. However, there is no information available at present
regarding systemic processing in recipients of gut-processed antigen.
In addition, reports of MHC restriction in the activation of
suppressor T cells indicate a requirement for accessory cells for
antigen recognition by at least some types of suppressor cell
(Reviewed, Germain and Benacerraf, 1981).
The possession of intact antibody-binding sites is in no way
indicative of an intact molecule and so the gel-filtration studies of
serum containing gut-processed OVA were useful in estimating the size
of the tolerogenic protein. Significant suppression of DTH was..
induced in recipients by the injection of a fraction of serum from
OVA-fed mice (FII), which contained proteins in the same molecular
weight range as native OVA and which also contained ELISA-detectable
OVA. Of all the serum fractions tested, only in FII could OVA be
detected by ELISA. These results suggest that the suppressive effect
of serum from OVA-fed mice is due to gut-processed OVA which is very
similar to native OVA in size and in its recognition by antibody. It
is however, extremely unlikely that the tolerogen is native OVA, even
*
in deaggregated form, since my experiments described previously showed
that native and deaggregated OVA both failed to reproduce the effect
of gut-processed OVA in vivo.
What then, is the molecular nature of gut-processed OVA? The
answer is beyond the scope of this thesis but my experiments have
opened up areas for the further investigation of this subject:
The suppressive serum fraction, FII, contained proteins within
the molecular weight range of 100,000 to 40,000 approximately.
Without using a more sensitive technique for the accurate resolution
of proteins and peptides such as high pressure liquid chromatography
(HPLC) it is impossible to pinpoint the exact molecular size of the
tolerogen. Further analysis of serum using HPLC techniques should be
able to reveal the presence of any subtle differences in molecular
weight between the tolerogenic OVA and native OVA.
Recent work by Streicher et al (1984) proposes that antigen
processing of some proteins involves the unfolding of at least part of
the molecule and exposition of hydrophobic areas for T cell
recognition. It would be exciting to test this hypothesis in an in
vivo situation by studying the relative hydrophobicities of
gut-processed OVA and native OVA.
Other work in the past, and also very recently has described the
presence of both suppressor epitopes (Sercarz ^et al, 1978; Adorini et
al 1979), and immunodominant epitopes (Berkower et _al_, 1984)
consisting of as few as 17 amino acids (Shimonkevitz et al, 1984), on
globular protein antigens for T cell recognition. Removal of such
epitopes alters the immune response to the native molecule. Further
study of gut-processed OVA might reveal either the exposition of a
suppressor epitope on the external surface of the molecule, or the
removal of an immunodominant epitope, or even both events occurring
simultaneously.
Another aspect of gut-processed OVA meriting further study is the
overall surface charge of the molecule. OVA which has been absorbed
across the intestinal mucosa has had to interact with epithelial cell
membranes. Since lymphocyte receptors classically bind to antigens
via non-covalent interactions, an altered surface charge occurring as
a result of absorption may influence the subsequent immune recognition
of antigen.
Further study of this tolerogenic molecule would be of value
towards our understanding of the regulation of immunity by antigen
feeding and also of immune recognition and regulation in general.
9.4 The Importance of Intestinal Function and GALT in the Induction
of Oral Tolerance
The experiments described in Chapter 8 revealed the importance of
the gut in generating tolerogenic OVA in serum after feeding. Damage
to the gut inflicted by irradiation prevented the production of the
tolerogen. OVA was detected in the serum of irradiated, OVA-fed mice
but was not tolerogenic in nature when transferred into recipients.
In addition, the systemic antigen dose in transferred serum was not
related to the induction of tolerance in recipients. The absence of
tolerogenic OVA in serum was noted when the intestinal crypts were in
a state of either hypoplasia at 2 days after irradiation, or
hyperplasia which was seen 5 days after irradiation, and therefore
seems not related to a specific type of abnormality in the gut.
One possible explanation for the loss of tolerogen production in
irradiated mice is that whole-body iradiation impairs proteolysis of
OVA in the intestine. The experiments of Strobel showed that40VA
which was administered to mice via the colon as an enema, and
therefore removed from the influence of gastric and pancreatic
enzymes, was effective in inducing systemic tolerance (Strobel, 1984).
Proteolysis may therefore be relatively unimportant in the production
of tolerogenic OVA by the gut.
Another reason for the loss of tolerance induction following
serum transfer from animals given whole-body irradiation, could be the
impaired clearance of immunogenic moities of OVA from the circulation,
due to either hepatic or renal dysfunction. These possiblities cannot
be excluded on the basis of experimental evidence in this thesis and
further work, perhaps involving the isolated irradiation of the
intestine should be able to clarify this situation.
The production of tolerogenic OVA by the gut was restored by an
injection of normal spleen cells. The experiments of Hanson on
similarly treated mice had shown that tolerance was not induced in
irradiated and reconstituted mice at 2 days after irradiation and
spleen cell transfer but was restored by 5 days (D. Hanson, personal
communication 1982). My results show that the intestine is not
impaired in its ability to produce a tolerogen at either of these time
points after irradiation and reconstitution.
Tolerogen production was restored whilst the animals were still
recovering from the effects of irradiation such as weight loss and
dehydration but had approaching normal numbers of jejunal
intraepithelial lymphocytes. This is an intriguing observation which
will require much more work before an explanation is available. The
apparent recovery of the numbers of IELs after an injection of spleen
cells, with the concomitant recovery of tolerogen production is
curious and several potential explanations can be put forward.
Either, that IELs are relevant to gut antigen processing or, perhaps
more likely, that the restored IEL count is coincidental, and the
re-population of lymphoid cells in GALT permits the development of
IELs which have no influence on gut processing but merely indicate the
restoration of some gut function including antigen processing. In
this case, the lymphoid compartment of the gut may be necessary for
antigen processing either by direct interaction with antigen or by
some secondary function in the maintenance of mucosal integrity. From
this point of view, phagocytic cells may be of importance in repairing
the radiation-damaged intestine and clearing lymphatic channels.
In any event, it can be concluded that the production of
tolerogenic OVA after feeding seems to be a facet of normal gut
function and may be dependent on lymphocytes.
One of the primary effects of irradiation is damage to cell
membranes. This has been observed in lymphocytes which were unable to
traffic normally following irradiation but which were still capable of
expressing effector function (Kettman and Mathews, 1976). If
lympho-epithelial interactions are relevant in the gut-processing of
OVA this could well be impaired by irradiation and restored by the
injection of healthy lymphoid cells.
9.5 Concluding Remarks
The work described in this thesis has shown that in adult mice,
protein uptake by the intestine is of profound immunological
significance.
Study of an end-product of the ingestion and absorption of a
soluble, globular protein antigen, ovalbumin, has been a useful aid in
visualizing interaction of the immune system with a normal
physiological sytem, that of the intestine, and has provided
information about the regulation of immunity as a consequence of
protein antigen ingestion.
Interaction between the gut and the immune system is potentially
of enormous importance to the well-being of an individual. Further
study of the immunological processes related to the intestine and of
their disruption for reasons either genetic, immunological, or
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